%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/


%% Created for sam harper at 2022-12-13 16:05:15 -0500 


%% Saved with string encoding Unicode (UTF-8) 



@article{Wasserstein:2019aa,
	author = {Wasserstein, Ronald L and Schirm, Allen L and Lazar, Nicole A},
	date-added = {2020-09-02 21:47:14 -0400},
	date-modified = {2020-09-02 22:02:27 -0400},
	journal = {The American Statistician},
	number = {sup1},
	pages = {1-19},
	publisher = {Taylor \& Francis},
	title = {Moving to a world beyond "p<0.05"},
	url = {10.1080/00031305.2019.1583913},
	volume = {73},
	year = {2019},
	bdsk-url-1 = {10.1080/00031305.2019.1583913}}

@article{McShane:2019aa,
	author = {McShane, Blakeley B and Gal, David and Gelman, Andrew and Robert, Christian and Tackett, Jennifer L},
	date-added = {2020-09-02 21:46:36 -0400},
	date-modified = {2020-09-02 22:02:27 -0400},
	journal = {The American Statistician},
	keywords = {https://doi.org/10.1080/00031305.2018.1527253},
	number = {sup1},
	pages = {235--245},
	publisher = {Taylor \& Francis},
	title = {Abandon statistical significance},
	volume = {73},
	year = {2019}}

@article{Wasserstein_2016,
	author = {Ronald L. Wasserstein and Nicole A. Lazar},
	date-added = {2020-09-02 21:46:22 -0400},
	date-modified = {2020-09-02 21:46:22 -0400},
	doi = {10.1080/00031305.2016.1154108},
	journal = {The American Statistician},
	month = {apr},
	number = {2},
	pages = {129--133},
	publisher = {Informa {UK} Limited},
	title = {The {ASA} Statement on p-Values: Context, Process, and Purpose},
	url = {https://doi.org/10.1080%2F00031305.2016.1154108},
	volume = {70},
	year = 2016,
	bdsk-url-1 = {https://doi.org/10.1080%2F00031305.2016.1154108},
	bdsk-url-2 = {https://doi.org/10.1080/00031305.2016.1154108}}

@article{Edwards:2020aa,
	abstract = {The COVID-19 pandemic and the coming transition to a post-pandemic world where COVID-19 will likely remain as an incident disease present a host of challenges and opportunities in epidemiologic research. The scale and universality of this disruption to life and health provide unique opportunities to study phenomena, and health challenges, in all branches of epidemiology, from the obvious infectious disease and social consequences, to less clear impacts on chronic disease and cancer. If we are to both take advantage of the largest natural experiment of our lifetimes, and provide evidence to inform the numerous public health and clinical decisions being made every day, we must act quickly to ask critical questions and develop new methods to answer them. In doing so we should build on each of our strengths and expertise, and try to provide new insights rather than becoming yet another voice commenting on the same set of questions with limited evidence.},
	author = {Edwards, Jessie K and Lessler, Justin},
	date-added = {2020-09-02 21:32:33 -0400},
	date-modified = {2020-09-02 21:32:33 -0400},
	doi = {10.1093/aje/kwaa159},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {coronavirus; epidemics; epidemiologic methods},
	month = {Jul},
	pmc = {PMC7454283},
	pmid = {32696035},
	pst = {aheadofprint},
	title = {What Now? Epidemiology in the Wake of a Pandemic},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa159}}

@article{Davey-Smith:2019aa,
	abstract = {In the last third of the 20th century, etiological epidemiology within academia in high-income countries shifted its primary concern from attempting to tackle the apparent epidemic of noncommunicable diseases to an increasing focus on developing statistical and causal inference methodologies. This move was mutually constitutive with the failure of applied epidemiology to make major progress, with many of the advances in understanding the causes of noncommunicable diseases coming from outside the discipline, while ironically revealing the infectious origins of several major conditions. Conversely, there were many examples of epidemiologic studies promoting ineffective interventions and little evident attempt to account for such failure. Major advances in concrete understanding of disease etiology have been driven by a willingness to learn about and incorporate into epidemiology developments in biology and cognate data science disciplines. If fundamental epidemiologic principles regarding the rooting of disease risk within populations are retained, recent methodological developments combined with increased biological understanding and data sciences capability should herald a fruitful post-Modern Epidemiology world.},
	author = {Davey Smith, George},
	date-added = {2020-09-02 21:25:52 -0400},
	date-modified = {2020-09-02 21:25:52 -0400},
	doi = {10.1093/aje/kwz064},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Bradford Hill; causal inference; history of epidemiology; liability models; methodology; stochasticity},
	mesh = {Causality; Epidemiologic Methods; Epidemiology; History, 20th Century; History, 21st Century; Humans; Models, Statistical; Noncommunicable Diseases; Precision Medicine; Textbooks as Topic},
	month = {08},
	number = {8},
	pages = {1410-1419},
	pmc = {PMC6670067},
	pmid = {30877306},
	pst = {ppublish},
	title = {Post-Modern Epidemiology: When Methods Meet Matter},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz064}}

@article{Kuller:2019aa,
	abstract = {Epidemiology is the study of epidemics. It is a biological science that includes expertise in many disciplines in social and behavioral sciences. Epidemiology is also a key component of preventive medicine and public health. Unfortunately, over recent years, academic epidemiology has lost its relationship with preventive medicine, as well as much of its focus on epidemics. The new "-omics" technologies to measure risk factors and phenotypes, and advances in genomics (e.g., host susceptibility) consistent with good epidemiology methods will likely enhance epidemiology research. There is a need based on these new technologies to modify training, especially for the first-level doctorate epidemiologist.},
	author = {Kuller, Lewis H},
	date-added = {2020-09-02 21:25:19 -0400},
	date-modified = {2020-09-02 21:25:19 -0400},
	doi = {10.1093/aje/kwy221},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {causality; cervical cancer; epidemics; genomics; preventive medicine; teaching},
	mesh = {Causality; Chronic Disease; Communicable Diseases; Data Collection; Environment; Epidemiologic Methods; Epidemiology; Humans; Population; Preventive Medicine; Public Health Practice; Risk Factors; Social Environment; Socioeconomic Factors},
	month = {05},
	number = {5},
	pages = {890-895},
	pmid = {30877293},
	pst = {ppublish},
	title = {Epidemiologists of the Future: Data Collectors or Scientists?},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwy221}}

@article{Glymour:2019aa,
	abstract = {Improvements in data resources and computational power provide important opportunities to ensure the continued relevance and growth of observational epidemiology. To achieve that promise, rigorous statistical analyses are important but not sufficient. We must prioritize articulating relevant research questions and developing strong study designs. Relevance depends on designing observational research so it delivers actionable clinical or population health evidence. Expanding data sources, including administrative records and data from emerging technologies such as sensors, can potentially be leveraged to improve study design, statistical power, measurement, and availability of evidence on diverse populations. With these advantages, particularly evidence on the heterogeneity of treatment effects, observational research can better guide design of randomized trials. Evidence on the heterogeneity of treatment effects is also essential to extend the evidence from randomized trials beyond the narrow range of settings and populations for which trials have been conducted. Machine learning tools will likely grow in importance in observational epidemiology in coming years, although we need careful attention to the appropriate uses of prediction models. Despite the potential of these innovations, they will only be useful if embedded in theoretical frameworks motivated by applied clinical and population health questions.},
	author = {Glymour, M Maria and Bibbins-Domingo, Kirsten},
	date-added = {2020-09-02 21:25:02 -0400},
	date-modified = {2020-09-02 21:25:02 -0400},
	doi = {10.1093/aje/kwz030},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {data sources; epidemiologic theory; heterogeneous treatment effects; machine learning; study design},
	mesh = {Data Collection; Epidemiologic Methods; Epidemiology; Humans; Interprofessional Relations; Machine Learning; Observational Studies as Topic; Population Health; Randomized Controlled Trials as Topic},
	month = {05},
	number = {5},
	pages = {836-839},
	pmid = {30865219},
	pst = {ppublish},
	title = {The Future of Observational Epidemiology: Improving Data and Design to Align With Population Health},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz030}}

@article{Diez-Roux:2019aa,
	abstract = {Epidemiology has always filled a unique space. It lies squarely at the intersection of the social and biological sciences as well as at the intersection of knowledge generation and the translation of that knowledge into actions. Today, new data sources, new methods, and continued population health problems create opportunities and challenges for epidemiology. In this commentary, 4 areas of opportunity for epidemiology are reviewed: 1) the continued value of precise description; 2) a rigorous yet broad and practical approach to drawing conclusions about causes; 3) embracing methodological diversity; and 4) retaining a strong connection to public health practice and policy.},
	author = {Diez Roux, Ana V},
	date-added = {2020-09-02 21:24:33 -0400},
	date-modified = {2020-09-02 21:24:33 -0400},
	doi = {10.1093/aje/kwz001},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {causal inference; evidence; multilevel study; public health practice; systems},
	mesh = {Causality; Data Accuracy; Epidemiologic Methods; Epidemiology; Humans; Observational Studies as Topic; Population Health; Public Health Practice; Systems Analysis},
	month = {05},
	number = {5},
	pages = {886-889},
	pmid = {30877287},
	pst = {ppublish},
	title = {The Unique Space of Epidemiology: Drawing on the Past to Project Into the Future},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz001}}

@article{Pearce:2007aa,
	author = {Pearce, Neil},
	date-added = {2020-09-02 21:24:02 -0400},
	date-modified = {2020-09-02 21:24:02 -0400},
	doi = {10.1093/ije/dym152},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Commerce; Epidemiology; Financial Support; Forecasting; Humans; Research Design},
	month = {Aug},
	number = {4},
	pages = {713-7},
	pmid = {17660194},
	pst = {ppublish},
	title = {Commentary: The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision},
	volume = {36},
	year = {2007},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dym152}}

@article{Pearce:2008aa,
	abstract = {Corporate influences on epidemiology have become stronger and more pervasive in the last few decades, particularly in the contentious fields of pharmacoepidemiology and occupational epidemiology. For every independent epidemiologist studying the side effects of medicines and the hazardous effects of industrial chemicals, there are several other epidemiologists hired by industry to attack the research and to debunk it as 'junk science'. In some instances these activities have gone as far as efforts to block publication. In many instances, academics have accepted industry funding which has not been acknowledged, and only the academic affiliations of the company-funded consultants have been listed. These activities are major threats to the integrity of the field, and its survival as a scientific discipline. There is no simple solution to these problems. However, for the last two decades there has been substantial discussion on ethics in epidemiology, partly in response to the unethical conduct of many industry-funded consultants. Professional organizations, such as the International Epidemiological Association, can play a major role in encouraging and supporting epidemiologists to assert positive principles of how science should work, and how it should be applied to public policy decisions, rather than simply having a list of what not to do.},
	author = {Pearce, Neil},
	date-added = {2020-09-02 21:24:01 -0400},
	date-modified = {2020-09-02 21:24:01 -0400},
	doi = {10.1093/ije/dym270},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Conflict of Interest; Epidemiologic Methods; Epidemiology; Female; Humans; Interprofessional Relations; Male; New Zealand; Practice Patterns, Physicians'; Professional Corporations},
	month = {Feb},
	number = {1},
	pages = {46-53},
	pmid = {18245050},
	pst = {ppublish},
	title = {Corporate influences on epidemiology},
	volume = {37},
	year = {2008},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dym270}}

@article{Phillips:2008aa,
	author = {Phillips, Carl V},
	date-added = {2020-09-02 21:23:19 -0400},
	date-modified = {2020-09-02 21:23:19 -0400},
	doi = {10.1093/ije/dym266},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Alberta; Conflict of Interest; Epidemiologic Research Design; Ethics, Business; Female; Humans; Interprofessional Relations; Male; Practice Patterns, Physicians'; Professional Corporations; Science; Scientific Misconduct},
	month = {Feb},
	number = {1},
	pages = {59-64; discussion 65-8},
	pmid = {18245053},
	pst = {ppublish},
	title = {Commentary: Lack of scientific influences on epidemiology},
	volume = {37},
	year = {2008},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dym266}}

@article{Lesko:2020aa,
	abstract = {There has been much debate about the relative emphasis of the field of epidemiology on causal inference. We believe this debate does short shrift to the breadth of the field. Epidemiologists answer myriad questions that are not causal and hypothesize about and investigate causal relationships without estimating causal effects. Descriptive studies face significant and often overlooked inferential and interpretational challenges; we briefly articulate some of them and argue that a more detailed treatment of biases that affect single-sample estimation problems would benefit all types of epidemiologic studies. Lumping all questions about causality creates ambiguity about the utility of different conceptual models and causal frameworks; 2 distinct types of causal questions include 1) hypothesis generation and theorization about causal structures and 2) hypothesis-driven causal effect estimation. The potential outcomes framework and causal graph theory help efficiently and reliably guide epidemiologic studies designed to estimate a causal effect to best leverage prior data, avoid cognitive fallacies, minimize biases, and understand heterogeneity in treatment effects. Appropriate matching of theoretical frameworks to research questions can increase the rigor of epidemiologic research and increase the utility of such research to improve public health.},
	author = {Lesko, Catherine R and Keil, Alexander P and Edwards, Jessie K},
	date-added = {2020-09-02 21:20:38 -0400},
	date-modified = {2020-09-02 21:20:38 -0400},
	doi = {10.1093/aje/kwaa030},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {bias; causality; descriptive studies; epidemiologic methods; inference},
	month = {Jun},
	number = {6},
	pages = {511-517},
	pmc = {PMC7368131},
	pmid = {32207771},
	pst = {ppublish},
	title = {The Epidemiologic Toolbox: Identifying, Honing, and Using the Right Tools for the Job},
	volume = {189},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa030}}

@article{Lau:2018aa,
	author = {Lau, Bryan and Duggal, Priya and Ehrhardt, Stephan},
	date-added = {2020-09-02 21:19:41 -0400},
	date-modified = {2020-09-02 21:19:41 -0400},
	doi = {10.1093/ije/dyy179},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Causality; Epidemiologic Methods; Epidemiology; Humans; Models, Theoretical},
	month = {10},
	number = {5},
	pages = {1366-1371},
	pmc = {PMC6208276},
	pmid = {30165517},
	pst = {ppublish},
	title = {Epidemiology at a time for unity},
	volume = {47},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyy179}}

@article{Mingle:2019aa,
	author = {Mingle, Jonathan},
	date-added = {2020-09-02 21:11:14 -0400},
	date-modified = {2020-09-02 21:15:15 -0400},
	journal = {New York Review of Books},
	number = {14},
	title = {Our Lethal Air},
	url = {https://www.nybooks.com/articles/2019/09/26/our-lethal-air-pollution/},
	volume = {66},
	year = {2019},
	bdsk-url-1 = {https://www.nybooks.com/articles/2019/09/26/our-lethal-air-pollution/}}

@electronic{Lee:aa,
	author = {Lee, Stephanie},
	date-added = {2020-09-02 21:06:23 -0400},
	date-modified = {2020-09-02 21:07:23 -0400},
	publisher = {BuzzFeed News},
	title = {An Elite Group Of Scientists Tried To Warn Trump Against Lockdowns In March},
	url = {https://www.buzzfeednews.com/article/stephaniemlee/ioannidis-trump-white-house-coronavirus-lockdowns},
	urldate = {2020-07-24},
	bdsk-url-1 = {https://www.brookings.edu/techstream/understanding-medical-uncertainty-in-the-hydroxychloroquine-debate/}}

@inbook{Savitz:2016aa,
	author = {Savitz, David A and Wellenius, Gregory A},
	chapter = {Characterization and Communication of Conclusions},
	date-added = {2020-09-02 20:58:42 -0400},
	date-modified = {2020-09-02 21:04:10 -0400},
	editor = {Savitz, David A and Wellenius, Gregory A},
	pages = {200--10},
	publisher = {Oxford University Press},
	series = {Characterization and Communication of Conclusions},
	title = {Interpreting epidemiologic evidence: connecting research to applications},
	year = {2016}}

@electronic{Khorana:aa,
	author = {Khorana, Smitha and Kellie Owens},
	date-added = {2020-09-02 20:54:30 -0400},
	date-modified = {2020-09-02 20:56:44 -0400},
	publisher = {Brookings Tech Stream},
	title = {Understanding medical uncertainty in the hydroxychloroquine debate},
	url = {https://www.brookings.edu/techstream/understanding-medical-uncertainty-in-the-hydroxychloroquine-debate/},
	urldate = {2020-07-23},
	bdsk-url-1 = {https://www.brookings.edu/techstream/understanding-medical-uncertainty-in-the-hydroxychloroquine-debate/}}

@article{Ladner:2019aa,
	abstract = {Advances in genomics and computing are transforming the capacity for the characterization of biological systems, and researchers are now poised for a precision-focused transformation in the way they prepare for, and respond to, infectious diseases. This includes the use of genome-based approaches to inform molecular diagnosis and individual-level treatment regimens. In addition, advances in the speed and granularity of pathogen genome generation have improved the capability to track and understand pathogen transmission, leading to potential improvements in the design and implementation of population-level public health interventions. In this Perspective, we outline several trends that are driving the development of precision epidemiology of infectious disease and their implications for scientists' ability to respond to outbreaks.},
	author = {Ladner, Jason T and Grubaugh, Nathan D and Pybus, Oliver G and Andersen, Kristian G},
	date-added = {2020-09-02 20:35:48 -0400},
	date-modified = {2020-09-02 20:35:48 -0400},
	doi = {10.1038/s41591-019-0345-2},
	journal = {Nat Med},
	journal-full = {Nature medicine},
	mesh = {Communicable Disease Control; Communicable Diseases; Disease Outbreaks; Genomics; Humans},
	month = {02},
	number = {2},
	pages = {206-211},
	pmc = {PMC7095960},
	pmid = {30728537},
	pst = {ppublish},
	title = {Precision epidemiology for infectious disease control},
	volume = {25},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1038/s41591-019-0345-2}}

@article{Chowkwanyun:2019aa,
	author = {Chowkwanyun, Merlin and Bayer, Ronald and Galea, Sandro},
	date-added = {2020-09-02 20:33:32 -0400},
	date-modified = {2020-09-02 20:33:32 -0400},
	doi = {10.1016/S0140-6736(18)33187-8},
	journal = {Lancet},
	journal-full = {Lancet (London, England)},
	month = {05},
	number = {10183},
	pages = {1801},
	pmid = {31057162},
	pst = {ppublish},
	title = {Precision public health: pitfalls and promises},
	volume = {393},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1016/S0140-6736(18)33187-8}}

@article{Chowkwanyun:2018aa,
	author = {Chowkwanyun, Merlin and Bayer, Ronald and Galea, Sandro},
	date-added = {2020-09-02 20:33:31 -0400},
	date-modified = {2020-09-02 20:43:03 -0400},
	doi = {10.1093/ije/dyy184},
	journal = {N Engl J Med},
	journal-full = {The New England journal of medicine},
	mesh = {Genomics; History, 19th Century; History, 20th Century; Humans; National Institutes of Health (U.S.); Precision Medicine; Public Health; Public Health Practice; United States},
	month = {Oct},
	number = {15},
	pages = {1398-1400},
	pmid = {30184442},
	pst = {ppublish},
	title = {"Precision" Public Health - Between Novelty and Hype},
	volume = {379},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1056/NEJMp1806634}}

@article{Khoury:2016aa,
	author = {Khoury, Muin J and Galea, Sandro},
	date-added = {2020-09-02 20:33:22 -0400},
	date-modified = {2020-09-02 20:33:22 -0400},
	doi = {10.1001/jama.2016.12260},
	journal = {JAMA},
	journal-full = {JAMA},
	mesh = {Disease; Health Impact Assessment; Health Status Indicators; Humans; Molecular Targeted Therapy; Precision Medicine; Preventive Medicine; Program Evaluation; Public Health; Research Support as Topic; Risk Assessment; Therapeutics; United States},
	month = {Oct},
	number = {13},
	pages = {1357-1358},
	pmc = {PMC6359904},
	pmid = {27541310},
	pst = {ppublish},
	title = {Will Precision Medicine Improve Population Health?},
	volume = {316},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1001/jama.2016.12260}}

@article{Rasmussen:2020aa,
	author = {Rasmussen, Sonja A and Khoury, Muin J and Del Rio, Carlos},
	date-added = {2020-09-02 20:33:10 -0400},
	date-modified = {2020-09-02 20:37:59 -0400},
	doi = {10.1093/ije/dyy184},
	journal = {JAMA},
	journal-full = {JAMA},
	month = {Aug},
	pmid = {32805001},
	pst = {aheadofprint},
	title = {Precision Public Health as a Key Tool in the COVID-19 Response},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1001/jama.2020.14992}}

@article{Taylor-Robinson:2019aa,
	author = {Taylor-Robinson, David and Kee, Frank},
	date-added = {2020-09-02 20:29:05 -0400},
	date-modified = {2020-09-02 20:29:05 -0400},
	doi = {10.1093/ije/dyy184},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiological Monitoring; Genomics; Humans; Precision Medicine; Public Health},
	month = {02},
	number = {1},
	pages = {1-6},
	pmc = {PMC6380317},
	pmid = {30212875},
	pst = {ppublish},
	title = {Precision public health-the Emperor's new clothes},
	volume = {48},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyy184}}

@article{Dahabreh:2020ab,
	abstract = {When treatment effect modifiers influence the decision to participate in a randomized trial, the average treatment effect in the population represented by the randomized individuals will differ from the effect in other populations. In this tutorial, we consider methods for extending causal inferences about time-fixed treatments from a trial to a new target population of nonparticipants, using data from a completed randomized trial and baseline covariate data from a sample from the target population. We examine methods based on modeling the expectation of the outcome, the probability of participation, or both (doubly robust). We compare the methods in a simulation study and show how they can be implemented in software. We apply the methods to a randomized trial nested within a cohort of trial-eligible patients to compare coronary artery surgery plus medical therapy versus medical therapy alone for patients with chronic coronary artery disease. We conclude by discussing issues that arise when using the methods in applied analyses.},
	author = {Dahabreh, Issa J and Robertson, Sarah E and Steingrimsson, Jon A and Stuart, Elizabeth A and Hern{\'a}n, Miguel A},
	date-added = {2020-09-02 18:47:48 -0400},
	date-modified = {2020-09-02 18:47:48 -0400},
	doi = {10.1002/sim.8426},
	journal = {Stat Med},
	journal-full = {Statistics in medicine},
	keywords = {double robustness; generalizability; observational analyses; randomized trials; transportability},
	month = {Jun},
	number = {14},
	pages = {1999-2014},
	pmid = {32253789},
	pst = {ppublish},
	title = {Extending inferences from a randomized trial to a new target population},
	volume = {39},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1002/sim.8426}}

@article{Dahabreh:2019aa,
	author = {Dahabreh, Issa J and Hern{\'a}n, Miguel A},
	date-added = {2020-09-02 18:47:47 -0400},
	date-modified = {2020-09-02 18:47:47 -0400},
	doi = {10.1007/s10654-019-00533-2},
	journal = {Eur J Epidemiol},
	journal-full = {European journal of epidemiology},
	mesh = {Evidence-Based Practice; Health Services Needs and Demand; Humans; Randomized Controlled Trials as Topic; Research Design},
	month = {Aug},
	number = {8},
	pages = {719-722},
	pmid = {31218483},
	pst = {ppublish},
	title = {Extending inferences from a randomized trial to a target population},
	volume = {34},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1007/s10654-019-00533-2}}

@article{Greenland:2016aa,
	abstract = {Misinterpretation and abuse of statistical tests, confidence intervals, and statistical power have been decried for decades, yet remain rampant. A key problem is that there are no interpretations of these concepts that are at once simple, intuitive, correct, and foolproof. Instead, correct use and interpretation of these statistics requires an attention to detail which seems to tax the patience of working scientists. This high cognitive demand has led to an epidemic of shortcut definitions and interpretations that are simply wrong, sometimes disastrously so-and yet these misinterpretations dominate much of the scientific literature. In light of this problem, we provide definitions and a discussion of basic statistics that are more general and critical than typically found in traditional introductory expositions. Our goal is to provide a resource for instructors, researchers, and consumers of statistics whose knowledge of statistical theory and technique may be limited but who wish to avoid and spot misinterpretations. We emphasize how violation of often unstated analysis protocols (such as selecting analyses for presentation based on the P values they produce) can lead to small P values even if the declared test hypothesis is correct, and can lead to large P values even if that hypothesis is incorrect. We then provide an explanatory list of 25 misinterpretations of P values, confidence intervals, and power. We conclude with guidelines for improving statistical interpretation and reporting.},
	author = {Greenland, Sander and Senn, Stephen J and Rothman, Kenneth J and Carlin, John B and Poole, Charles and Goodman, Steven N and Altman, Douglas G},
	date-added = {2020-09-02 18:38:31 -0400},
	date-modified = {2020-09-02 18:38:31 -0400},
	doi = {10.1007/s10654-016-0149-3},
	journal = {Eur J Epidemiol},
	journal-full = {European journal of epidemiology},
	keywords = {Confidence intervals; Hypothesis testing; Null testing; P value; Power; Significance tests; Statistical testing},
	mesh = {Confidence Intervals; Data Interpretation, Statistical; Humans; Probability},
	month = {04},
	number = {4},
	pages = {337-50},
	pmc = {PMC4877414},
	pmid = {27209009},
	pst = {ppublish},
	title = {Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations},
	volume = {31},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1007/s10654-016-0149-3}}

@article{DeVilbiss:2020ab,
	abstract = {Using web-based survey data collected June - August 2018 from the Society for Epidemiologic Research (SER) members, we characterized numerous dimensions of social identity and lived experience, and assessed relationships between these characteristics and perceptions of inclusion and society participation. We quantified associations between characteristics, feeling very welcomed, high (top 25th percentile) self-initiated participation, and any (top 10th percentile) society-initiated participation. Racial/ethnic and religious minority categories were blinded to preserve anonymity and we accounted for missing data. Most 2018 SER members (n = 1631) were white (62%) or female (66%). Females with racial/ethnic non-response were least likely, while white males were most likely to report feeling very welcomed. Members who did not report race, identified with a specific racial/ethnic minority, or were politically conservative/right-leaning were less likely than white or liberal/left-leaning members to have high self-initiated participation. Women and individuals of a specific racial/ethnic minority or minority religious affiliations were less likely to participate in events initiated by the society. These data represent a baseline for assessing trends and the impact of future initiatives aimed at improving diversity, inclusion, representation and participation within SER.},
	author = {DeVilbiss, Elizabeth A and Weuve, Jennifer and Fink, David S and Morris, Meghan D and Arah, Onyebuchi A and Radoc, Jeannie G and Datta, Geetanjali D and Abuelezam, Nadia N and Lopez, David S and Johnson, Dayna A and Branas, Charles C and Schisterman, Enrique F},
	date-added = {2020-09-02 18:35:03 -0400},
	date-modified = {2020-09-02 18:35:03 -0400},
	doi = {10.1093/aje/kwz281},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {continental population groups; cultural diversity; demography; ethnic groups; sex; social participation; societies},
	month = {Jan},
	pmid = {31907518},
	pst = {aheadofprint},
	title = {Assessing Representation and Perceived Inclusion among Members in the Society for Epidemiologic Research},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz281}}

@article{Dahabreh:2020aa,
	author = {Dahabreh, Issa J and Robins, James M and Hern{\'a}n, Miguel A},
	date-added = {2020-09-02 18:21:53 -0400},
	date-modified = {2020-09-02 18:21:53 -0400},
	doi = {10.1097/EDE.0000000000001231},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	month = {Sep},
	number = {5},
	pages = {614-619},
	pmid = {32740470},
	pst = {ppublish},
	title = {Benchmarking Observational Methods by Comparing Randomized Trials and Their Emulations},
	volume = {31},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000001231}}

@article{Lodi:2019aa,
	abstract = {Effect estimates from randomized trials and observational studies might not be directly comparable because of differences in study design, other than randomization, and in data analysis. We propose a 3-step procedure to facilitate meaningful comparisons of effect estimates from randomized trials and observational studies: 1) harmonization of the study protocols (eligibility criteria, treatment strategies, outcome, start and end of follow-up, causal contrast) so that the studies target the same causal effect, 2) harmonization of the data analysis to estimate the causal effect, and 3) sensitivity analyses to investigate the impact of discrepancies that could not be accounted for in the harmonization process. To illustrate our approach, we compared estimates of the effect of immediate with deferred initiation of antiretroviral therapy in individuals positive for the human immunodeficiency virus from the Strategic Timing of Antiretroviral Therapy (START) randomized trial and the observational HIV-CAUSAL Collaboration.},
	author = {Lodi, Sara and Phillips, Andrew and Lundgren, Jens and Logan, Roger and Sharma, Shweta and Cole, Stephen R and Babiker, Abdel and Law, Matthew and Chu, Haitao and Byrne, Dana and Horban, Andrzej and Sterne, Jonathan A C and Porter, Kholoud and Sabin, Caroline and Costagliola, Dominique and Abgrall, Sophie and Gill, John and Touloumi, Giota and Pacheco, Antonio G and van Sighem, Ard and Reiss, Peter and Bucher, Heiner C and Montoliu Gim{\'e}nez, Alexandra and Jarrin, Inmaculada and Wittkop, Linda and Meyer, Laurence and Perez-Hoyos, Santiago and Justice, Amy and Neaton, James D and Hern{\'a}n, Miguel A and {INSIGHT START Study Group and the HIV-CAUSAL Collaboration}},
	date-added = {2020-09-02 18:20:57 -0400},
	date-modified = {2020-09-02 18:20:57 -0400},
	doi = {10.1093/aje/kwz100},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {antiretroviral initiation; causal inference; per-protocol effect; target trial},
	mesh = {Adult; Anti-Retroviral Agents; Epidemiologic Methods; Female; HIV Infections; Humans; Male; Middle Aged; Observational Studies as Topic; Randomized Controlled Trials as Topic; Research Design},
	month = {08},
	number = {8},
	pages = {1569-1577},
	pmc = {PMC6670045},
	pmid = {31063192},
	pst = {ppublish},
	title = {Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz100}}

@article{Glymour:2017aa,
	abstract = {Counterfactual frameworks and statistical methods for supporting causal inference are powerful tools to clarify scientific questions and guide analyses in public health research. Counterfactual accounts of causation contrast what would happen to a population's health under alternative exposure scenarios. A long-standing debate in counterfactual theory relates to whether sex, race, and biological characteristics, including obesity, should be evaluated as causes, given that these variables do not directly correspond to clearly defined interventions. We argue that sex, race, and biological characteristics are important health determinants. Quantifying the overall health effects of these variables is often a natural starting point for disparities research. Subsequent assessments of biological or social pathways mediating those effects can facilitate the development of interventions designed to reduce disparities.},
	author = {Glymour, M Maria and Spiegelman, Donna},
	date-added = {2020-09-02 18:13:59 -0400},
	date-modified = {2020-09-02 18:13:59 -0400},
	doi = {10.2105/AJPH.2016.303539},
	journal = {Am J Public Health},
	journal-full = {American journal of public health},
	mesh = {Biological Factors; Causality; Confounding Factors, Epidemiologic; Ethnic Groups; Female; Health Services Research; Humans; Male; Models, Statistical; Prejudice; Public Health; Research Design; Sex Factors},
	month = {Jan},
	number = {1},
	pages = {81-85},
	pmc = {PMC5308179},
	pmid = {27854526},
	pst = {ppublish},
	title = {Evaluating Public Health Interventions: 5. Causal Inference in Public Health Research-Do Sex, Race, and Biological Factors Cause Health Outcomes?},
	volume = {107},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.2105/AJPH.2016.303539}}

@article{Glymour:2014aa,
	author = {Glymour, Clark and Glymour, Madelyn R},
	date-added = {2020-09-02 18:13:38 -0400},
	date-modified = {2020-09-02 18:13:38 -0400},
	doi = {10.1097/EDE.0000000000000122},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	mesh = {Causality; Continental Population Groups; Humans},
	month = {Jul},
	number = {4},
	pages = {488-90},
	pmid = {24887161},
	pst = {ppublish},
	title = {Commentary: race and sex are causes},
	volume = {25},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000122}}

@article{Kaufman:2019aa,
	abstract = {Social epidemiology seeks to describe and quantify the causal effects of social institutions, interactions, and structures on human health. To accomplish this task, we define exposures as treatments and posit populations exposed or unexposed to these well-defined regimens. This inferential structure allows us to unambiguously estimate and interpret quantitative causal parameters and to investigate how these may be affected by biases such as confounding. This paradigm has been challenged recently by some critics who favor broadening the exposures that may be studied beyond treatments to also consider states. Defining the exposure protocol of an observational study is a continuum of specificity, and one may choose to loosen this definition, incurring the cost of causal parameters that become commensurately more vague. The advantages and disadvantages of broader versus narrower definitions of exposure are matters of continuing debate in social epidemiology as in other branches of epidemiology.},
	author = {Kaufman, Jay S},
	date-added = {2020-09-02 18:12:37 -0400},
	date-modified = {2020-09-02 18:12:37 -0400},
	doi = {10.1146/annurev-publhealth-040218-043735},
	journal = {Annu Rev Public Health},
	journal-full = {Annual review of public health},
	keywords = {causal inference; confounding; counterfactual; quasi-experimental; race/ethnicity; social determinants; well-defined exposure},
	mesh = {Causality; Confounding Factors, Epidemiologic; Epidemiologic Studies; Humans; Public Health; Social Determinants of Health},
	month = {04},
	pages = {7-21},
	pmid = {30601720},
	pst = {ppublish},
	title = {Commentary: Causal Inference for Social Exposures},
	volume = {40},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1146/annurev-publhealth-040218-043735}}

@article{Kaufman:2020aa,
	author = {Kaufman, Jay S},
	date-added = {2020-09-02 18:12:16 -0400},
	date-modified = {2020-09-02 18:12:16 -0400},
	doi = {10.1093/ije/dyaa096},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {Jun},
	pmid = {32594156},
	pst = {aheadofprint},
	title = {Commentary: Cynical epidemiology},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyaa096}}

@article{Knox:2020aa,
	author = {Knox, Dean and Lowe, Will and Mummolo, Jonathan},
	date-added = {2020-09-02 18:09:49 -0400},
	date-modified = {2020-09-02 18:09:56 -0400},
	journal = {American Political Science Review},
	number = {3},
	pages = {619--637},
	publisher = {Cambridge University Press},
	title = {Administrative records mask racially biased policing},
	volume = {114},
	year = {2020}}

@article{Gaebler:2020aa,
	author = {Gaebler, Johann and Cai, William and Basse, Guillaume and Shroff, Ravi and Goel, Sharad and Hill, Jennifer},
	date-added = {2020-09-02 18:06:49 -0400},
	date-modified = {2020-09-02 18:08:47 -0400},
	journal = {arXiv preprint arXiv:2006.12460},
	title = {Deconstructing claims of post-treatment bias in observational studies of discrimination},
	url = {https://arxiv.org/abs/2006.12460},
	year = {2020},
	bdsk-url-1 = {https://arxiv.org/abs/2006.12460}}

@article{Poole:2017ab,
	author = {Poole, Charles},
	date-added = {2020-09-02 18:01:51 -0400},
	date-modified = {2020-09-02 18:01:51 -0400},
	doi = {10.1097/EDE.0000000000000644},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	month = {05},
	number = {3},
	pages = {e32-e33},
	pmid = {28368968},
	pst = {ppublish},
	title = {The Author Responds},
	volume = {28},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000644}}

@article{Poole:2017aa,
	author = {Poole, Charles},
	date-added = {2020-09-02 18:01:47 -0400},
	date-modified = {2020-09-02 18:01:47 -0400},
	doi = {10.1097/EDE.0000000000000577},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	month = {01},
	number = {1},
	pages = {6-11},
	pmid = {27755277},
	pst = {ppublish},
	title = {Commentary: Some Thoughts on Consequential Epidemiology and Causal Architecture},
	volume = {28},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000577}}

@article{Keyes:2017ab,
	author = {Keyes, Katherine M and Galea, Sandro},
	date-added = {2020-09-02 18:01:45 -0400},
	date-modified = {2020-09-02 18:01:45 -0400},
	doi = {10.1097/EDE.0000000000000578},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	mesh = {Causality; Epidemiology; Risk Factors},
	month = {01},
	number = {1},
	pages = {1-5},
	pmc = {PMC5130600},
	pmid = {27755276},
	pst = {ppublish},
	title = {Commentary: The Limits of Risk Factors Revisited: Is It Time for a Causal Architecture Approach?},
	volume = {28},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000578}}

@article{Keyes:2017aa,
	author = {Keyes, Katherine M and Galea, Sandro},
	date-added = {2020-09-02 18:01:40 -0400},
	date-modified = {2020-09-02 18:01:40 -0400},
	doi = {10.1097/EDE.0000000000000643},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	month = {05},
	number = {3},
	pages = {e31-e32},
	pmc = {PMC5557702},
	pmid = {28212139},
	pst = {ppublish},
	title = {Re: Some Thoughts on Consequential Epidemiology and Causal Architecture},
	volume = {28},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000643}}

@article{VanderWeele:2016ab,
	author = {VanderWeele, Tyler J},
	date-added = {2020-09-02 17:54:42 -0400},
	date-modified = {2020-09-02 17:54:42 -0400},
	doi = {10.1093/ije/dyw230},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {12},
	number = {6},
	pages = {1809-1816},
	pmc = {PMC5841618},
	pmid = {28130319},
	pst = {ppublish},
	title = {Commentary: On Causes, Causal Inference, and Potential Outcomes},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw230}}

@article{Krieger:2016ab,
	abstract = {'Causal inference', in 21st century epidemiology, has notably come to stand for a specific approach, one focused primarily on counterfactual and potential outcome reasoning and using particular representations, such as directed acyclic graphs (DAGs) and Bayesian causal nets. In this essay, we suggest that in epidemiology no one causal approach should drive the questions asked or delimit what counts as useful evidence. Robust causal inference instead comprises a complex narrative, created by scientists appraising, from diverse perspectives, different strands of evidence produced by myriad methods. DAGs can of course be useful, but should not alone wag the causal tale. To make our case, we first address key conceptual issues, after which we offer several concrete examples illustrating how the newly favoured methods, despite their strengths, can also: (i) limit who and what may be deemed a 'cause', thereby narrowing the scope of the field; and (ii) lead to erroneous causal inference, especially if key biological and social assumptions about parameters are poorly conceived, thereby potentially causing harm. As an alternative, we propose that the field of epidemiology consider judicious use of the broad and flexible framework of 'inference to the best explanation', an approach perhaps best developed by Peter Lipton, a philosopher of science who frequently employed epidemiologically relevant examples. This stance requires not only that we be open to being pluralists about both causation and evidence but also that we rise to the challenge of forging explanations that, in Lipton's words, aspire to 'scope, precision, mechanism, unification and simplicity'.},
	author = {Krieger, Nancy and Davey Smith, George},
	date-added = {2020-09-02 17:52:38 -0400},
	date-modified = {2020-09-02 23:38:05 -0400},
	doi = {10.1093/ije/dyw231},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Algorithms; Causality; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Epidemiologic Methods; Humans},
	month = {12},
	number = {6},
	pages = {1787-1808},
	pmid = {27694566},
	pst = {ppublish},
	title = {The tale wagged by the DAG: broadening the scope of causal inference and explanation for epidemiology},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw114}}

@article{Krieger:2016aa,
	author = {Krieger, Nancy and Davey Smith, George},
	date-added = {2020-09-02 17:48:38 -0400},
	date-modified = {2020-09-02 17:48:38 -0400},
	doi = {10.1093/ije/dyw330},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {12},
	number = {6},
	pages = {1852-1865},
	pmid = {28130315},
	pst = {ppublish},
	title = {Response: FACEing reality: productive tensions between our epidemiological questions, methods and mission},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw330}}

@article{Robins:2016aa,
	author = {Robins, James M and Weissman, Michael B},
	date-added = {2020-09-02 17:48:15 -0400},
	date-modified = {2020-09-02 17:48:15 -0400},
	doi = {10.1093/ije/dyw231},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {12},
	number = {6},
	pages = {1830-1835},
	pmc = {PMC5841619},
	pmid = {28130321},
	pst = {ppublish},
	title = {Commentary: Counterfactual causation and streetlamps: what is to be done?},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw231}}

@article{VanderWeele:2016aa,
	author = {VanderWeele, Tyler J and Hern{\'a}n, Miguel A and Tchetgen Tchetgen, Eric J and Robins, James M},
	date-added = {2020-09-02 17:44:08 -0400},
	date-modified = {2020-09-02 17:44:08 -0400},
	doi = {10.1093/ije/dyw162},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {12},
	number = {6},
	pages = {2199-2200},
	pmid = {27524811},
	pst = {ppublish},
	title = {Re: Causality and causal inference in epidemiology: the need for a pluralistic approach},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw162}}

@article{Vandenbroucke:2016aa,
	abstract = {Causal inference based on a restricted version of the potential outcomes approach reasoning is assuming an increasingly prominent place in the teaching and practice of epidemiology. The proposed concepts and methods are useful for particular problems, but it would be of concern if the theory and practice of the complete field of epidemiology were to become restricted to this single approach to causal inference. Our concerns are that this theory restricts the questions that epidemiologists may ask and the study designs that they may consider. It also restricts the evidence that may be considered acceptable to assess causality, and thereby the evidence that may be considered acceptable for scientific and public health decision making. These restrictions are based on a particular conceptual framework for thinking about causality. In Section 1, we describe the characteristics of the restricted potential outcomes approach (RPOA) and show that there is a methodological movement which advocates these principles, not just for solving particular problems, but as ideals for which epidemiology as a whole should strive. In Section 2, we seek to show that the limitation of epidemiology to one particular view of the nature of causality is problematic. In Section 3, we argue that the RPOA is also problematic with regard to the assessment of causality. We argue that it threatens to restrict study design choice, to wrongly discredit the results of types of observational studies that have been very useful in the past and to damage the teaching of epidemiological reasoning. Finally, in Section 4 we set out what we regard as a more reasonable 'working hypothesis' as to the nature of causality and its assessment: pragmatic pluralism.},
	author = {Vandenbroucke, Jan P and Broadbent, Alex and Pearce, Neil},
	date-added = {2020-09-02 17:44:08 -0400},
	date-modified = {2020-09-02 17:44:08 -0400},
	doi = {10.1093/ije/dyv341},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Causality; Epidemiology; Humans; Models, Theoretical; Philosophy; Reproducibility of Results; Research Design; Risk Assessment; Risk Factors},
	month = {12},
	number = {6},
	pages = {1776-1786},
	pmc = {PMC5841832},
	pmid = {26800751},
	pst = {ppublish},
	title = {Causality and causal inference in epidemiology: the need for a pluralistic approach},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyv341}}

@article{Broadbent:2016aa,
	author = {Broadbent, Alex and Vandenbroucke, Jan P and Pearce, Neil},
	date-added = {2020-09-02 17:44:02 -0400},
	date-modified = {2020-09-02 17:44:02 -0400},
	doi = {10.1093/ije/dyw298},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Causality; Cultural Diversity; Epidemiology; Humans},
	month = {12},
	number = {6},
	pages = {1841-1851},
	pmc = {PMC5841621},
	pmid = {28130316},
	pst = {ppublish},
	title = {Response: Formalism or pluralism? A reply to commentaries on 'Causality and causal inference in epidemiology'},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw298}}

@article{Weed:2016aa,
	author = {Weed, Douglas L},
	date-added = {2020-09-02 17:43:59 -0400},
	date-modified = {2020-09-02 17:43:59 -0400},
	doi = {10.1093/ije/dyw229},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Causality; Cultural Diversity; Epidemiology; Humans; Peer Review; Risk Factors},
	month = {12},
	number = {6},
	pages = {1838-1840},
	pmid = {28130322},
	pst = {ppublish},
	title = {Commentary: Causal inference in epidemiology: potential outcomes, pluralism and peer review},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw229}}

@article{Blakely:2016aa,
	author = {Blakely, Tony and Lynch, John and Bentley, Rebecca},
	date-added = {2020-09-02 17:40:14 -0400},
	date-modified = {2020-09-02 17:40:14 -0400},
	doi = {10.1093/ije/dyw228},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {12},
	number = {6},
	pages = {1835-1837},
	pmid = {28130323},
	pst = {ppublish},
	title = {Commentary: DAGs and the restricted potential outcomes approach are tools, not theories of causation},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw228}}

@article{Daniel:2016aa,
	author = {Daniel, Rhian M and De Stavola, Bianca L and Vansteelandt, Stijn},
	date-added = {2020-09-02 17:39:54 -0400},
	date-modified = {2020-09-02 17:39:54 -0400},
	doi = {10.1093/ije/dyw227},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Causality; Epidemiology; Humans; Models, Statistical},
	month = {12},
	number = {6},
	pages = {1817-1829},
	pmc = {PMC5841837},
	pmid = {28130320},
	pst = {ppublish},
	title = {Commentary: The formal approach to quantitative causal inference in epidemiology: misguided or misrepresented?},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw227}}

@article{Ioannidis:2020aa,
	author = {Ioannidis, John P A},
	date-added = {2020-09-02 15:52:27 -0400},
	date-modified = {2020-09-02 15:53:23 -0400},
	journal = {Boston Review},
	month = {May 26},
	title = {The Totality of the Evidence},
	url = {https://bostonreview.net/science-nature/john-p-ioannidis-totality-evidence},
	year = {2020},
	bdsk-url-1 = {http://bostonreview.net/science-nature/jonathan-fuller-models-v-evidence}}

@article{Manski:2019aa,
	abstract = {The term "policy analysis" describes scientific evaluations of the impacts of past public policies and predictions of the outcomes of potential future policies. A prevalent practice has been to report policy analysis with incredible certitude. That is, exact predictions of policy outcomes are routine, while expressions of uncertainty are rare. However, predictions and estimates often are fragile, resting on unsupported assumptions and limited data. Therefore, the expressed certitude is not credible. This paper summarizes my work documenting incredible certitude and calling for transparent communication of uncertainty. I present a typology of practices that contribute to incredible certitude, give illustrative examples, and offer suggestions on how to communicate uncertainty.},
	author = {Manski, Charles F},
	date-added = {2020-09-02 14:38:35 -0400},
	date-modified = {2020-09-02 14:38:35 -0400},
	doi = {10.1073/pnas.1722389115},
	journal = {Proc Natl Acad Sci U S A},
	journal-full = {Proceedings of the National Academy of Sciences of the United States of America},
	keywords = {communication of uncertainty; incredible certitude; policy analysis},
	mesh = {Communication; Deception; Economics; Humans; Policy Making; Politics; Public Policy; Uncertainty; United States},
	month = {04},
	number = {16},
	pages = {7634-7641},
	pmc = {PMC6475410},
	pmid = {30478061},
	pst = {ppublish},
	title = {Communicating uncertainty in policy analysis},
	volume = {116},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1073/pnas.1722389115}}

@article{Haushofer:2020aa,
	author = {Haushofer, Johannes and Metcalf, C Jessica E},
	date-added = {2020-09-02 12:51:32 -0400},
	date-modified = {2020-09-02 12:51:32 -0400},
	doi = {10.1126/science.abb6144},
	journal = {Science},
	journal-full = {Science (New York, N.Y.)},
	mesh = {Communicable Disease Control; Coronavirus Infections; Hand Disinfection; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; Risk Reduction Behavior; SARS Virus; Sneezing},
	month = {Jun},
	number = {6495},
	pages = {1063-1065},
	pmid = {32439658},
	pst = {ppublish},
	title = {Which interventions work best in a pandemic?},
	volume = {368},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1126/science.abb6144}}

@article{VanderWeele:2014aa,
	abstract = {We consider several possible interpretations of the "effect of race" when regressions are run with race as an exposure variable, controlling also for various confounding and mediating variables. When adjustment is made for socioeconomic status early in a person's life, we discuss under what contexts the regression coefficients for race can be interpreted as corresponding to the extent to which a racial inequality would remain if various socioeconomic distributions early in life across racial groups could be equalized. When adjustment is also made for adult socioeconomic status, we note how the overall racial inequality can be decomposed into the portion that would be eliminated by equalizing adult socioeconomic status across racial groups and the portion of the inequality that would remain even if adult socioeconomic status across racial groups were equalized. We also discuss a stronger interpretation of the effect of race (stronger in terms of assumptions) involving the joint effects of race-associated physical phenotype (eg, skin color), parental physical phenotype, genetic background, and cultural context when such variables are thought to be hypothetically manipulable and if adequate control for confounding were possible. We discuss some of the challenges with such an interpretation. Further discussion is given as to how the use of selected populations in examining racial disparities can additionally complicate the interpretation of the effects. },
	author = {VanderWeele, Tyler J and Robinson, Whitney R},
	date-added = {2020-09-02 12:45:10 -0400},
	date-modified = {2020-09-02 12:45:10 -0400},
	doi = {10.1097/EDE.0000000000000105},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	mesh = {African Continental Ancestry Group; Causality; Confounding Factors, Epidemiologic; Continental Population Groups; Ethnic Groups; European Continental Ancestry Group; Humans; Phenotype; Regression Analysis; Socioeconomic Factors},
	month = {Jul},
	number = {4},
	pages = {473-84},
	pmc = {PMC4125322},
	pmid = {24887159},
	pst = {ppublish},
	title = {On the causal interpretation of race in regressions adjusting for confounding and mediating variables},
	volume = {25},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000105}}

@article{Huitfeldt:2019aa,
	abstract = {The participants in randomized trials and other studies used for causal inference are often not representative of the populations seen by clinical decision-makers. To account for differences between populations, researchers may consider standardizing results to a target population. We discuss several different types of homogeneity conditions that are relevant for standardization: Homogeneity of effect measures, homogeneity of counterfactual outcome state transition parameters, and homogeneity of counterfactual distributions. Each of these conditions can be used to show that a particular standardization procedure will result in an unbiased estimate of the effect in the target population, given assumptions about the relevant scientific context. We compare and contrast the homogeneity conditions, in particular their implications for selection of covariates for standardization and their implications for how to compute the standardized causal effect in the target population. While some of the recently developed counterfactual approaches to generalizability rely upon homogeneity conditions that avoid many of the problems associated with traditional approaches, they often require adjustment for a large (and possibly unfeasible) set of covariates.},
	author = {Huitfeldt, Anders and Swanson, Sonja A and Stensrud, Mats J and Suzuki, Etsuji},
	date-added = {2020-09-02 12:43:20 -0400},
	date-modified = {2020-09-02 12:43:20 -0400},
	doi = {10.1007/s10654-019-00571-w},
	journal = {Eur J Epidemiol},
	journal-full = {European journal of epidemiology},
	keywords = {Effect heterogeneity; Effect measures; External validity; Generalizability; Methodology; Standardization},
	mesh = {Health Services Needs and Demand; Humans; Models, Statistical; Models, Theoretical; Patient Selection; Randomized Controlled Trials as Topic; Reference Standards},
	month = {Dec},
	number = {12},
	pages = {1119-1129},
	pmid = {31655945},
	pst = {ppublish},
	title = {Effect heterogeneity and variable selection for standardizing causal effects to a target population},
	volume = {34},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1007/s10654-019-00571-w}}

@article{Xie:2013aa,
	author = {Xie, Yu},
	date-added = {2020-09-02 12:40:29 -0400},
	date-modified = {2020-09-02 12:40:41 -0400},
	journal = {Proceedings of the National Academy of Sciences},
	number = {16},
	pages = {6262--6268},
	publisher = {National Acad Sciences},
	title = {Population heterogeneity and causal inference},
	volume = {110},
	year = {2013}}

@article{Nilsson:2019aa,
	abstract = {When analyzing effect heterogeneity, the researcher commonly opts for stratification or a regression model with interactions. While these methods provide valuable insights, their usefulness can be somewhat limited, since they typically fail to take into account heterogeneity with respect to many dimensions simultaneously, or give rise to models with complex appearances. Based on the potential outcomes framework and through imputation of missing potential outcomes, our study proposes a method for analyzing heterogeneous effects by focusing on treatment effects rather than outcomes. The procedure is easy to implement and generates estimates that take into account heterogeneity with respect to all relevant dimensions at the same time. Results are easily interpreted and can additionally be represented by graphs, showing the overall magnitude and pattern of heterogeneity as well as how this relates to different factors. We illustrate the method both with simulations and by examining heterogeneous effects of obesity on HDL cholesterol in the Malm{\"o} Diet and Cancer cardiovascular cohort. Obesity was associated with reduced HDL in almost all individuals, but effects varied with smoking, risky alcohol consumption, higher education, and energy intake, with some indications of non-linear effects. Our approach can be applied by any epidemiologist who wants to assess the role and strength of heterogeneity with respect to a multitude of factors.},
	author = {Nilsson, Anton and Bonander, Carl and Str{\"o}mberg, Ulf and Bj{\"o}rk, Jonas},
	date-added = {2020-09-02 12:39:28 -0400},
	date-modified = {2020-09-02 12:39:28 -0400},
	doi = {10.1007/s10654-019-00551-0},
	journal = {Eur J Epidemiol},
	journal-full = {European journal of epidemiology},
	keywords = {Causal inference; Heterogeneity; Imputation; Potential outcomes},
	mesh = {Alcohol Drinking; Cholesterol, HDL; Educational Status; Energy Intake; Epidemiology; Humans; Models, Statistical; Obesity; Research Design; Smoking},
	month = {Sep},
	number = {9},
	pages = {823-835},
	pmc = {PMC6759690},
	pmid = {31420761},
	pst = {ppublish},
	title = {Assessing heterogeneous effects and their determinants via estimation of potential outcomes},
	volume = {34},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1007/s10654-019-00551-0}}

@article{Matthay:2020ab,
	abstract = {Directed acyclic graphs (DAGs), a prominent tool for expressing assumptions in epidemiologic research, are most useful when the hypothetical data generating structure is correctly encoded. Understanding a study's data generating structure and translating that data structure into a DAG can be challenging, but these skills are often glossed over in training. Campbell and Stanley's framework for causal inference has been extraordinarily influential in social science training programs but has received less attention in epidemiology. Their work, along with subsequent revisions and enhancements based on practical experience conducting empirical studies, presents a catalog of 37 threats to validity describing reasons empirical studies may fail to deliver causal effects. We interpret most of these threats to study validity as suggestions for common causal structures. Threats are organized into issues of statistical conclusion validity, internal validity, construct validity, or external validity. To assist epidemiologists in drawing the correct DAG for their application, we map the correspondence between threats to validity and epidemiologic concepts that can be represented with DAGs. Representing these threats as DAGs makes them amenable to formal analysis with d-separation rules and breaks down cross-disciplinary language barriers in communicating methodologic issues.},
	author = {Matthay, Ellicott C and Glymour, M Maria},
	date-added = {2020-09-02 12:33:43 -0400},
	date-modified = {2020-09-02 12:33:43 -0400},
	doi = {10.1097/EDE.0000000000001161},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	month = {May},
	number = {3},
	pages = {376-384},
	pmc = {PMC7144753},
	pmid = {31977593},
	pst = {ppublish},
	title = {A Graphical Catalog of Threats to Validity: Linking Social Science with Epidemiology},
	volume = {31},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000001161}}

@article{Lesko:2017aa,
	abstract = {Great care is taken in epidemiologic studies to ensure the internal validity of causal effect estimates; however, external validity has received considerably less attention. When the study sample is not a random sample of the target population, the sample average treatment effect, even if internally valid, cannot usually be expected to equal the average treatment effect in the target population. The utility of an effect estimate for planning purposes and decision making will depend on the degree of departure from the true causal effect in the target population due to problems with both internal and external validity. Herein, we review concepts from recent literature on generalizability, one facet of external validity, using the potential outcomes framework. Identification conditions sufficient for external validity closely parallel identification conditions for internal validity, namely conditional exchangeability; positivity; the same distributions of the versions of treatment; no interference; and no measurement error. We also require correct model specification. Under these conditions, we discuss how a version of direct standardization (the g-formula, adjustment formula, or transport formula) or inverse probability weighting can be used to generalize a causal effect from a study sample to a well-defined target population, and demonstrate their application in an illustrative example.},
	author = {Lesko, Catherine R and Buchanan, Ashley L and Westreich, Daniel and Edwards, Jessie K and Hudgens, Michael G and Cole, Stephen R},
	date-added = {2020-09-02 12:19:44 -0400},
	date-modified = {2020-09-02 12:19:44 -0400},
	doi = {10.1097/EDE.0000000000000664},
	journal = {Epidemiology},
	journal-full = {Epidemiology (Cambridge, Mass.)},
	mesh = {Bias; Causality; Epidemiologic Methods; Female; Humans; Male; Predictive Value of Tests; Reproducibility of Results; Statistics as Topic; United States},
	month = {07},
	number = {4},
	pages = {553-561},
	pmc = {PMC5466356},
	pmid = {28346267},
	pst = {ppublish},
	title = {Generalizing Study Results: A Potential Outcomes Perspective},
	volume = {28},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1097/EDE.0000000000000664}}

@article{Westreich:2019aa,
	abstract = {In recent years, increasing attention has been paid to problems of external validity, specifically to methodological approaches for both quantitative generalizability and transportability of study results. However, most approaches to these issues have considered external validity separately from internal validity. Here we argue that considering either internal or external validity in isolation may be problematic. Further, we argue that a joint measure of the validity of an effect estimate with respect to a specific population of interest may be more useful: We call this proposed measure target validity. In this work, we introduce and formally define target bias as the total difference between the true causal effect in the target population and the estimated causal effect in the study sample, and target validity as target bias = 0. We illustrate this measure with a series of examples and show how this measure may help us to think more clearly about comparisons between experimental and nonexperimental research results. Specifically, we show that even perfect internal validity does not ensure that a causal effect will be unbiased in a specific target population.},
	author = {Westreich, Daniel and Edwards, Jessie K and Lesko, Catherine R and Cole, Stephen R and Stuart, Elizabeth A},
	date-added = {2020-09-02 12:19:38 -0400},
	date-modified = {2020-09-02 12:19:38 -0400},
	doi = {10.1093/aje/kwy228},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	mesh = {Bias; Causality; Epidemiologic Methods; Humans; Reproducibility of Results},
	month = {02},
	number = {2},
	pages = {438-443},
	pmc = {PMC6357801},
	pmid = {30299451},
	pst = {ppublish},
	title = {Target Validity and the Hierarchy of Study Designs},
	volume = {188},
	year = {2019},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwy228}}

@article{Groenwold:2020aa,
	author = {Groenwold, Rolf H H},
	date-added = {2020-09-02 11:20:15 -0400},
	date-modified = {2020-09-02 11:20:15 -0400},
	doi = {10.1093/ije/dyaa092},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {Jun},
	pmid = {32594115},
	pst = {aheadofprint},
	title = {Commentary: Quantifying the unknown unknowns},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyaa092}}

@article{Stang:2014aa,
	author = {Stang, Andreas and J{\"o}ckel, Karl-Heinz},
	date-added = {2020-09-02 11:16:06 -0400},
	date-modified = {2020-09-02 11:16:06 -0400},
	doi = {10.1093/ije/dyt263},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Apr},
	number = {2},
	pages = {630-1},
	pmid = {24408970},
	pst = {ppublish},
	title = {Avoidance of representativeness in presence of effect modification},
	volume = {43},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt263}}

@article{Rothman:2013aa,
	author = {Rothman, Kenneth J and Gallacher, John E J and Hatch, Elizabeth E},
	date-added = {2020-09-02 11:10:41 -0400},
	date-modified = {2020-09-02 11:10:41 -0400},
	doi = {10.1093/ije/dyt124},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Aug},
	number = {4},
	pages = {1026-8},
	pmc = {PMC3781006},
	pmid = {24062292},
	pst = {ppublish},
	title = {Rebuttal: When it comes to scientific inference, sometimes a cigar is just a cigar},
	volume = {42},
	year = {2013},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt124}}

@article{Acosta:2020aa,
	abstract = {In 2013-2014, an outbreak involving 14 patients infected by an extensively drug-resistant strain of Pseudomonas aeruginosa was detected in a hospital in Madrid, Spain. Our objective was to evaluate an alternative strategy for investigating the outbreak in depth by means of molecular and genomic approaches. Pulsed-field gel electrophoresis (PFGE) was applied as a first-line approach, followed by a more refined whole genome sequencing analysis. Single nucleotide polymorphisms identified by whole genome sequencing were used to design a specific polymerase chain reaction (PCR) for screening unsuspected cases infected by the outbreak strain. Whole genome sequencing alerted us to the existence of greater genetic diversity than was initially assumed, splitting the PFGE-associated outbreak isolates into 4 groups, 2 of which represented coincidental transmission unrelated to the outbreak. A multiplex allele-specific PCR targeting outbreak-specific single nucleotide polymorphisms was applied to 290 isolates, which allowed us to identify 25 additional cases related to the outbreak during 2011-2017. Whole genome sequencing coupled with an outbreak-strain-specific PCR enabled us to markedly redefine the initial picture of the outbreak by 1) ruling out initially suspected cases, 2) defining likely independent coincidental transmission events, 3) predating the starting point of the outbreak, 4) capturing new unsuspected cases, and 5) revealing that the outbreak was still active.},
	author = {Acosta, Ferm{\'\i}n and Fern{\'a}ndez-Cruz, Ana and Maus, Sandra R and Sola-Campoy, Pedro J and Mar{\'\i}n, Mercedes and Cercenado, Emilia and Sierra, Olalla and Mu{\~n}oz, Patricia and Garc{\'\i}a de Viedma, Dar{\'\i}o and P{\'e}rez-Lago, Laura},
	date-added = {2020-09-02 11:10:26 -0400},
	date-modified = {2020-09-02 11:10:26 -0400},
	doi = {10.1093/aje/kwaa025},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Pseudomonas aeruginosa ; drug resistance; genomics; infection; nosocomial outbreaks; polymerase chain reaction},
	month = {Aug},
	number = {8},
	pages = {841-849},
	pmid = {32128575},
	pst = {ppublish},
	title = {In-Depth Study of a Nosocomial Outbreak Caused by Extensively Drug-Resistant Pseudomonas aeruginosa Using Whole Genome Sequencing Coupled With a Polymerase Chain Reaction Targeting Strain-Specific Single Nucleotide Polymorphisms},
	volume = {189},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa025}}

@article{Johnson:2020aa,
	abstract = {Scientific conferences provide attendees opportunities to network, share research, learn new skills and ideas, and initiate collaborations. Conference attendance is especially important for students and early career researchers who are establishing their research careers or looking for jobs. However, attending conferences can be expensive, and the high cost of conference attendance may hit students and early career researchers the hardest. According to a new member survey from the Society for Epidemiologic Research, early career members are more racially and ethnically diverse than senior members, meaning that reducing financial barriers to conference participation may be an important consideration for increasing diversity among conference attendees. In this commentary, we discuss how choice of conference location-choosing less expensive cities nearer to more Society for Epidemiologic Research members-could reduce financial and other barriers to conference attendance for all members and improve diversity and inclusion in the Society.},
	author = {Johnson, Candice Y and Chin, Helen B},
	date-added = {2020-09-02 11:10:24 -0400},
	date-modified = {2020-09-02 11:10:24 -0400},
	doi = {10.1093/aje/kwaa107},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Society for Epidemiologic Research; diversity; early career; epidemiology; inclusion},
	month = {Jun},
	pmid = {32602521},
	pst = {aheadofprint},
	title = {Improving Diversity and Promoting Inclusion in the Society for Epidemiologic Research Through Choice of Conference Location},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa107}}

@article{Doan:2020aa,
	abstract = {We present interpretations of the idea that "epidemiologists count" in response to the current status of membership and diversity and inclusion efforts within the Society for Epidemiological Research (SER). We review who epidemiologists count to describe the (mis)representation of SER membership and how categorizations of people reflect social constructions of identity and biases that exist in broader society. We argue that what epidemiologists count - how diversity and inclusion are operationalized - has real-world implications on institutional norms and how inclusive/non-inclusive environments are. Lastly, we examine which epidemiologists count within the field and argue that inclusion can only be achieved when we address how resources and opportunities are distributed among epidemiologists. To improve diversity and inclusion within SER and beyond, we recommend that SER strengthen its commitment to diversity, inclusion and equity by: (1) integrating this priority on all agendas; (2) enhancing efforts to improve self-awareness among members and accountability within the organization; (3) supporting the growth of a diversifying workforce in epidemiology; and (4) increasing the visibility of health disparities research and researchers in epidemiology.},
	author = {o{\`a}n, Lan N and Bacong, Adrian M and Ma, Kris Pui Kwan and Morey, Brittany N},
	date-added = {2020-09-02 11:10:23 -0400},
	date-modified = {2020-09-02 11:10:23 -0400},
	doi = {10.1093/aje/kwaa108},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {diversity; health equity; inclusion; social epidemiology},
	month = {Jun},
	pmid = {32602522},
	pst = {aheadofprint},
	title = {"Epidemiologists Count": The Role of Diversity and Inclusion in the Field of Epidemiology},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa108}}

@article{Odo:2020aa,
	author = {Odo, Nnaemeka U},
	date-added = {2020-09-02 11:10:22 -0400},
	date-modified = {2020-09-02 11:10:22 -0400},
	doi = {10.1093/aje/kwaa113},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	month = {Jun},
	pmid = {32602523},
	pst = {aheadofprint},
	title = {Diversity, (Equity) and inclusion: Easily ignored issues in academia},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa113}}

@article{Jackson:2020aa,
	abstract = {The authors of the DeVilbiss et al. manuscript have taken on the noble and worthy cause to improve diversity, inclusion, representation, and participation across the Society for Epidemiologic Research (SER) membership - a reflection/microcosm of society. The objective of this commentary is to underscore the importance of diversity and to offer initiative ideas, which should be centered around inequity stemming from the widespread historical and contemporary maldistribution of power (e.g., decision making) and resources (e.g., funding) within institutions/organizations. Non-exhaustive strategies could include SER becoming an opportunity and information hub that helps to fill resource gaps. It is also recommended that SER leadership learn from existing associations and scientific initiatives to improve the culture of science in general by equitably incorporating policy, systems, and environmental interventions throughout the career spectrum. Examples include the provision of tools and/or incentives to address explicit/implicit biases, enhance mentoring skills, and remove predictable barriers (e.g., financial). Explicitly labeling diversity/inclusion efforts should be avoided, and the initiative should be evaluated based on impact vs intent. Our fates are interconnected, and we can all help increase diversity, inclusion, representation, and participation to improve our science in hopes of equitably improving public health.},
	author = {Jackson, Chandra L},
	date-added = {2020-09-02 11:10:21 -0400},
	date-modified = {2020-09-02 11:10:21 -0400},
	doi = {10.1093/aje/kwaa104},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Diversity; Inclusion; Leadership; Mentoring; Social Identification; Social Marginalization},
	month = {Jun},
	pmid = {32602525},
	pst = {aheadofprint},
	title = {A Smorgasbord of Opportunities Exist to Improve Diversity, Inclusion, Representation, and Participation in Epidemiology: More Informed Action is Necessary Since Current Approaches are Insufficient},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa104}}

@article{Bovbjerg:2020aa,
	abstract = {The Society for Epidemiologic Research (SER) has recently taken laudable steps towards increasing diversity, equity, and inclusion within the society, including participation in the Annual Meeting. In this essay, we argue that there is one critical piece of the diversity and inclusion equation that is, however, overlooked: institution. At the 2019 Annual Meeting, a mere 8 institutions accounted for a disproportionate number of both oral concurrent sessions and symposium speakers. This lack of institutional diversity, unless addressed, will hinder SER's ability to address other aspects of diversity, equity, and inclusion.},
	author = {Bovbjerg, Marit L and Misra, Dawn and Snowden, Jonathan M},
	date-added = {2020-09-02 11:10:19 -0400},
	date-modified = {2020-09-02 11:10:19 -0400},
	doi = {10.1093/aje/kwaa106},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {cultural diversity; universities},
	month = {Jun},
	pmid = {32602526},
	pst = {aheadofprint},
	title = {You're From... Where, Again? A Critical Assessment of Institutional Diversity in the Society for Epidemiologic Research},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa106}}

@article{Kamineni:2020aa,
	author = {Kamineni, Aruna and Vupputuri, Suma},
	date-added = {2020-09-02 11:10:18 -0400},
	date-modified = {2020-09-02 11:10:18 -0400},
	doi = {10.1093/aje/kwaa115},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	month = {Jun},
	pmid = {32602527},
	pst = {aheadofprint},
	title = {Letter to editor: challenges in evaluating diversity and inclusion in scientific communities},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa115}}

@article{Gilman:2020aa,
	abstract = {The mission of the Diversity and Inclusion Committee (D&I) in the Society for Epidemiologic Research is to foster the diversity of our membership and work towards the engagement of all members, from diverse backgrounds at all stages of their careers, in the Society's activities, with the intent of enhancing discovery in public health. As a foundational step in implementing our mission, the D&I committee conducted a survey of SER membership. In our commentary, we report on the efforts we have undertaken to expand the diversity and inclusiveness of our Society and our aspirations for future efforts in support of D&I. Early on, we established the SERvisits program to conduct outreach to institutions and students that have historically been under-represented at SER; we hope this program continues to grow in its reach and impact. We have also taken steps to increase the inclusiveness of SER activities, for example, by engaging members on issues of D&I through symposia and workshops at SER annual meetings and through social media. DeVilbiss et al.'s results demonstrate that there is substantial room for improvement with regards to diversity and inclusion within SER. We invite SER members to become involved and collaborate on this long-term goal.},
	author = {Gilman, Stephen E and Arah, Onyebuchi A and Bates, Lisa and Branas, Charles C and Cozier, Yvette C and Datta, Geetanjali D and DeVilbiss, Elizabeth A and Fink, David S and Hajat, Anjum and Johnson, Dayna A and Lopez, David S and Morris, Meghan D and Weuve, Jennifer and Abuelezam, Nadia N and {Diversity and Inclusion Committee of the Society for Epidemiologic Research}},
	date-added = {2020-09-02 11:10:18 -0400},
	date-modified = {2020-09-02 11:10:18 -0400},
	doi = {10.1093/aje/kwaa109},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Diversity; Epidemiology; Inclusion},
	month = {Jun},
	pmid = {32602528},
	pst = {aheadofprint},
	title = {The Society for Epidemiologic Research (SER) and the Future of Diversity and Inclusion in Epidemiology1},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa109}}

@article{Balkus:2020aa,
	author = {Balkus, Jennifer E and Hajat, Anjum and Rowhani-Rahbar, Ali and Tornberg-Belanger, Stephanie N},
	date-added = {2020-09-02 11:10:17 -0400},
	date-modified = {2020-09-02 11:10:17 -0400},
	doi = {10.1093/aje/kwaa116},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	month = {Jun},
	pmid = {32602535},
	pst = {aheadofprint},
	title = {In pursuit of consequential epidemiology: where is diversity and inclusion?},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa116}}

@article{Puac-Polanco:2020aa,
	abstract = {With the growing recognition that diversity and inclusion are essential for the improvement of science and innovation, this commentary provides some perspectives on three findings in the DeVilbiss et al. (2020)'s article and provide points of discussion on factors and strategies to consider when drafting diversity and inclusion programs for the Society for Epidemiologic Research.},
	author = {Puac-Polanco, Victor and Morabia, Alfredo},
	date-added = {2020-09-02 11:10:16 -0400},
	date-modified = {2020-09-02 11:10:16 -0400},
	doi = {10.1093/aje/kwaa112},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Cultural Diversity},
	month = {Jun},
	pmid = {32602536},
	pst = {aheadofprint},
	title = {A Diverse and Inclusive Academic Membership for All},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa112}}

@article{Allen:2020aa,
	abstract = {The positive effects of increased diversity and inclusion in scientific research and practice are well documented. In this issue, Devilbiss and colleagues (Am J Epidemiol. 2020) present findings from a survey that sought to characterize diversity among epidemiologists and perceptions of inclusion in the epidemiologic profession. They capture identity across a range of personal characteristics, including race, gender, socioeconomic background, sexual orientation, religion, and political leaning. This commentary asserts that the inclusion of political leaning as an axis of identity alongside the others captured undermines the larger project of promoting diversity and inclusion in the profession and is symptomatic of the movement for "ideological diversity" in higher education. We identify why political leaning is not an appropriate metric of diversity and detail why prioritizing ideological diversity counterintuitively can work against equity building initiatives. As an alternative to ideological diversity, we propose that epidemiologists take up an existing framework for research and practice that centers the voices and perspectives of historically marginalized populations in epidemiologic work.},
	author = {Allen, Bennett and Lewis, Ashley},
	date-added = {2020-09-02 11:10:15 -0400},
	date-modified = {2020-09-02 11:10:15 -0400},
	doi = {10.1093/aje/kwaa102},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {Public Health Critical Race Praxis; diversity; equity; ideological diversity; inclusion},
	month = {Jun},
	pmid = {32602537},
	pst = {aheadofprint},
	title = {Diversity and political leaning: Considerations for epidemiology},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa102}}

@article{Becerra:2020aa,
	abstract = {Increasing participation by promoting diversity and inclusion in professional society membership has become an important topic for many scientific fields. In a recent issue of AJE, DeVilbiss et al reported results from a survey conducted by the SER Diversity and Inclusion Committee in which they measured several aspects of participation by sociodemographic and cultural variables among its members, Here, we summarize the major findings of their survey, put their results within the greater context of the epidemiology workforce, and provide suggestions on how the committee could expand its influence by considering measuring variables related to career outcomes and trajectories. This suggestion is based on an attempt to link the interventions being facilitated by SER, the participation indices it is trying to improve, and the greater mission of the SER to build sustainable career trajectories that produce the best science that will improve the health of human populations.},
	author = {Becerra, Adan Z and Ekundayo, Olugbemiga and Salahuddin, Meliha and Onasanya, Tosin and Li, Shanshan and {``Navigating Careers as a Person of Color'' Society of Epidemiological Research Pilot Mentoring Group}},
	date-added = {2020-09-02 11:10:15 -0400},
	date-modified = {2020-09-02 11:10:15 -0400},
	doi = {10.1093/aje/kwaa105},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {diversity; epidemiology; inclusion},
	month = {Jun},
	pmid = {32602543},
	pst = {aheadofprint},
	title = {Diversity and Inclusion in the Epidemiology Workforce, a Response to DeVilbiss et al},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa105}}

@article{DeVilbiss:2020aa,
	author = {DeVilbiss, Elizabeth A and Weuve, Jennifer and Fink, David S and Arah, Onyebuchi A and Radoc, Jeannie G and Datta, Geetanjali D and Lopez, David S and Johnson, Dayna A and Branas, Charles C and Schisterman, Enrique F and {Society for Epidemiologic Research Diversity and Inclusion Committee}},
	date-added = {2020-09-02 11:10:13 -0400},
	date-modified = {2020-09-02 11:10:13 -0400},
	doi = {10.1093/aje/kwaa103},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	month = {Jun},
	pmid = {32602539},
	pst = {aheadofprint},
	title = {Response to SER Diversity and Inclusion Survey Commentaries},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa103}}

@article{Zhang:2020aa,
	abstract = {Increasing diverse engagement in the Society of Epidemiologic Research (SER) will positively impact the field of epidemiology. SER has long been a pioneer in promoting diversity and inclusion as the largest and longest running epidemiologic society in North America. A recent survey of SER members, however, showed there is still room for improving diversity, inclusion, representation, and participation in the Society. In this commentary, as members of both SER and the Johns Hopkins Bloomberg School of Public Health (JHSPH) Department of Epidemiology's Inclusion, Diversity, Equity, and Science (Epi-IDEAS) working group, we recommend four goals for the SER Annual Meeting and beyond: 1) Convene epidemiologic researchers with diverse backgrounds and ideas, 2) Promote an inclusive environment at the SER Annual Meeting, 3) Develop, compile, and disseminate best practices to honor diversity in epidemiologic research, and 4) Increase prioritization of health disparities research and methods. We also suggest strategies to achieve these goals so that SER can better include, support, and elevate members from historically disadvantaged groups. While our recommendations are tailored specifically to SER, the greater epidemiologic and academic communities could benefit from adopting these goals and strategies within their professional societies and conferences.},
	author = {Zhang, Mingyu and Jarrett, Brooke A and Althoff, Keri N and Burman, Frances S and Camarata, Laura and Coburn, Sally B and Dickerson, Aisha S and Foti, Kathryn and Kaur, Maneet and Leifheit, Kathryn M and Malone, Jowanna and Moore, Ebony A and Mouslim, Morgane C and Menezes, Neia Prata and Robsky, Katherine and Tang, Olive and Wallace, Amelia S and Dean, Lorraine T},
	date-added = {2020-09-02 11:10:13 -0400},
	date-modified = {2020-09-02 11:10:13 -0400},
	doi = {10.1093/aje/kwaa110},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {continental population groups; cultural diversity; epidemiology; health equity; health status disparities; minority groups; sex; sexual and gender minorities},
	month = {Jun},
	pmid = {32602548},
	pst = {aheadofprint},
	title = {Recommendations for the Society for Epidemiologic Research to Further Promote Diversity and Inclusion at the Annual Meeting and Beyond},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa110}}

@article{Moore:2020aa,
	abstract = {Increasing diversity and inclusion among organizational membership has become a focus for many professional societies, including the Society for Epidemiologic Research (SER). The accompanying article by DeVilbiss et al. assessed dimensions of diversity and inclusion within SER to provide baseline data for future evaluations of Society initiatives. In our response to this article, we note that diversity in SER appears strong but lags with regards to inclusion. We also highlight some of the major weaknesses of this study that hinder efforts to accurately evaluate inclusion within SER. There is a need to more concretely define inclusion and think broadly about how measures of inclusion should be operationalized in future surveys. Additional limitations of the study include its limited generalizability to the wider SER membership, and the lack of questions about barriers to inclusion in SER activities. We conclude with recommendations for SER and other professional societies based on prior literature evaluating successful diversity and inclusion efforts. We also propose a conceptual model to assist with operationalizing and directing future analyses of inclusion measures. It is essential that SER move beyond efforts around diversity to focus on measuring and enhancing inclusion.},
	author = {Moore, Kristin J and Xiong, Serena and Bhattacharya, Manami and Bustamante, Gabriela and Calvert, Collin},
	date-added = {2020-09-02 11:10:12 -0400},
	date-modified = {2020-09-02 11:10:12 -0400},
	doi = {10.1093/aje/kwaa111},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {diversity; inclusion; professional organization; representation},
	month = {Jun},
	pmid = {32602893},
	pst = {aheadofprint},
	title = {Beyond Diversity: Focusing on and enhancing inclusion in the Society for Epidemiologic Research (SER)},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa111}}

@misc{Oliver:2016aa,
	author = {Oliver, John},
	booktitle = {Last Week Tonight with John Oliver},
	date-added = {2020-09-02 08:29:34 -0400},
	date-modified = {2020-09-02 08:39:30 -0400},
	month = {May 8},
	number = {Episoide 11},
	title = {Scientific Studies},
	url = {https://www.youtube.com/watch?v=0Rnq1NpHdmw},
	urldate = {2016-05-08},
	volume = {Season 3},
	year = {2016},
	bdsk-url-1 = {https://www.youtube.com/watch?v=0Rnq1NpHdmw}}

@article{Lipsitch:2020ab,
	author = {Lipsitch, Marc},
	date-added = {2020-09-01 22:59:38 -0400},
	date-modified = {2020-09-01 22:59:38 -0400},
	doi = {10.1007/s10654-020-00651-2},
	journal = {Eur J Epidemiol},
	journal-full = {European journal of epidemiology},
	month = {Jun},
	number = {6},
	pages = {519-522},
	pmc = {PMC7305476},
	pmid = {32564181},
	pst = {ppublish},
	title = {Good science is good science: we need specialists, not sects},
	volume = {35},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1007/s10654-020-00651-2}}

@article{Kissler:2020aa,
	abstract = {It is urgent to understand the future of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for human coronavirus OC43 (HCoV-OC43) and HCoV-HKU1 using time-series data from the United States to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained because a resurgence in contagion could be possible as late as 2024.},
	author = {Kissler, Stephen M and Tedijanto, Christine and Goldstein, Edward and Grad, Yonatan H and Lipsitch, Marc},
	date-added = {2020-09-01 22:58:47 -0400},
	date-modified = {2020-09-01 22:58:47 -0400},
	doi = {10.1126/science.abb5793},
	journal = {Science},
	journal-full = {Science (New York, N.Y.)},
	mesh = {Betacoronavirus; Coronavirus Infections; Coronavirus OC43, Human; Disease Outbreaks; Disease Transmission, Infectious; Humans; Models, Biological; Pandemics; Pneumonia, Viral; Seasons},
	month = {05},
	number = {6493},
	pages = {860-868},
	pmc = {PMC7164482},
	pmid = {32291278},
	pst = {ppublish},
	title = {Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period},
	volume = {368},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1126/science.abb5793}}

@article{Ioannidis:2014aa,
	abstract = {In a 2005 paper that has been accessed more than a million times, John Ioannidis explained why most published research findings were false. Here he revisits the topic, this time to address how to improve matters. Please see later in the article for the Editors' Summary. },
	author = {Ioannidis, John P A},
	date-added = {2020-09-01 22:00:46 -0400},
	date-modified = {2020-09-01 22:00:46 -0400},
	doi = {10.1371/journal.pmed.1001747},
	journal = {PLoS Med},
	journal-full = {PLoS medicine},
	mesh = {Publications; Publishing; Research},
	month = {Oct},
	number = {10},
	pages = {e1001747},
	pmc = {PMC4204808},
	pmid = {25334033},
	pst = {epublish},
	title = {How to make more published research true},
	volume = {11},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1371/journal.pmed.1001747}}

@article{Goodman:2016aa,
	abstract = {The language and conceptual framework of "research reproducibility" are nonstandard and unsettled across the sciences. In this Perspective, we review an array of explicit and implicit definitions of reproducibility and related terminology, and discuss how to avoid potential misunderstandings when these terms are used as a surrogate for "truth."},
	author = {Goodman, Steven N and Fanelli, Daniele and Ioannidis, John P A},
	date-added = {2020-09-01 22:00:24 -0400},
	date-modified = {2020-09-01 22:00:24 -0400},
	doi = {10.1126/scitranslmed.aaf5027},
	journal = {Sci Transl Med},
	journal-full = {Science translational medicine},
	mesh = {Biomedical Research; Reproducibility of Results},
	month = {06},
	number = {341},
	pages = {341ps12},
	pmid = {27252173},
	pst = {ppublish},
	title = {What does research reproducibility mean?},
	volume = {8},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1126/scitranslmed.aaf5027}}

@article{Lipsitch:2020aa,
	author = {Lipsitch, Marc},
	date-added = {2020-09-01 21:18:10 -0400},
	date-modified = {2020-09-01 21:18:44 -0400},
	journal = {Boston Review},
	month = {May 12},
	title = {Good science is good science},
	url = {https://bostonreview.net/science-nature/marc-lipsitch-good-science-good-science},
	year = {2020},
	bdsk-url-1 = {http://bostonreview.net/science-nature/jonathan-fuller-models-v-evidence}}

@article{Fuller:2020aa,
	author = {Fuller, Jonathan},
	date-added = {2020-09-01 21:15:02 -0400},
	date-modified = {2020-09-01 21:16:40 -0400},
	journal = {Boston Review},
	month = {May 5},
	title = {Models v. evidence},
	url = {http://bostonreview.net/science-nature/jonathan-fuller-models-v-evidence},
	year = {2020},
	bdsk-url-1 = {http://bostonreview.net/science-nature/jonathan-fuller-models-v-evidence}}

@article{Ebrahim:2016aa,
	author = {Ebrahim, Shah and Ferrie, Jane E and Davey Smith, George},
	date-added = {2020-09-01 21:10:37 -0400},
	date-modified = {2020-09-01 21:10:37 -0400},
	doi = {10.1093/ije/dyx032},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiology; Forecasting; Humans; Periodicals as Topic},
	month = {12},
	number = {6},
	pages = {1699-1716},
	pmid = {28375510},
	pst = {ppublish},
	title = {The future of epidemiology: methods or matter?},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyx032}}

@article{Deaton:2018ab,
	author = {Deaton, Angus and Cartwright, Nancy},
	date-added = {2020-09-01 20:31:12 -0400},
	date-modified = {2020-09-01 20:31:12 -0400},
	doi = {10.1016/j.socscimed.2018.04.046},
	journal = {Soc Sci Med},
	journal-full = {Social science \& medicine (1982)},
	mesh = {Humans; Randomized Controlled Trials as Topic; Social Medicine; Social Sciences},
	month = {08},
	pages = {86-90},
	pmid = {29731150},
	pst = {ppublish},
	title = {Reflections on Randomized Control Trials},
	volume = {210},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1016/j.socscimed.2018.04.046}}

@article{Suzuki:2018aa,
	author = {Suzuki, Etsuji and VanderWeele, Tyler J},
	date-added = {2020-09-01 20:29:43 -0400},
	date-modified = {2020-09-01 20:29:43 -0400},
	doi = {10.1016/j.socscimed.2018.04.023},
	journal = {Soc Sci Med},
	journal-full = {Social science \& medicine (1982)},
	mesh = {Comprehension; Data Interpretation, Statistical; Randomized Controlled Trials as Topic; Uncertainty},
	month = {08},
	pages = {83-85},
	pmid = {29703448},
	pst = {ppublish},
	title = {Mechanisms and uncertainty in randomized controlled trials: A commentary on Deaton and Cartwright},
	volume = {210},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1016/j.socscimed.2018.04.023}}

@article{Dahabreh:2018aa,
	author = {Dahabreh, Issa J},
	date-added = {2020-09-01 20:19:35 -0400},
	date-modified = {2020-09-01 20:19:35 -0400},
	doi = {10.1016/j.socscimed.2018.05.012},
	journal = {Soc Sci Med},
	journal-full = {Social science \& medicine (1982)},
	mesh = {Random Allocation; Randomized Controlled Trials as Topic},
	month = {08},
	pages = {41-44},
	pmid = {30001875},
	pst = {ppublish},
	title = {Randomization, randomized trials, and analyses using observational data: A commentary on Deaton and Cartwright},
	volume = {210},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1016/j.socscimed.2018.05.012}}

@article{Imbens:2018aa,
	author = {Imbens, Guido},
	date-added = {2020-09-01 20:18:06 -0400},
	date-modified = {2020-09-01 20:18:06 -0400},
	doi = {10.1016/j.socscimed.2018.04.028},
	journal = {Soc Sci Med},
	journal-full = {Social science \& medicine (1982)},
	mesh = {Comprehension; Randomized Controlled Trials as Topic},
	month = {08},
	pages = {50-52},
	pmid = {29735351},
	pst = {ppublish},
	title = {Understanding and misunderstanding randomized controlled trials: A commentary on Deaton and Cartwright},
	volume = {210},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1016/j.socscimed.2018.04.028}}

@article{Deaton:2018aa,
	abstract = {Randomized Controlled Trials (RCTs) are increasingly popular in the social sciences, not only in medicine. We argue that the lay public, and sometimes researchers, put too much trust in RCTs over other methods of investigation. Contrary to frequent claims in the applied literature, randomization does not equalize everything other than the treatment in the treatment and control groups, it does not automatically deliver a precise estimate of the average treatment effect (ATE), and it does not relieve us of the need to think about (observed or unobserved) covariates. Finding out whether an estimate was generated by chance is more difficult than commonly believed. At best, an RCT yields an unbiased estimate, but this property is of limited practical value. Even then, estimates apply only to the sample selected for the trial, often no more than a convenience sample, and justification is required to extend the results to other groups, including any population to which the trial sample belongs, or to any individual, including an individual in the trial. Demanding 'external validity' is unhelpful because it expects too much of an RCT while undervaluing its potential contribution. RCTs do indeed require minimal assumptions and can operate with little prior knowledge. This is an advantage when persuading distrustful audiences, but it is a disadvantage for cumulative scientific progress, where prior knowledge should be built upon, not discarded. RCTs can play a role in building scientific knowledge and useful predictions but they can only do so as part of a cumulative program, combining with other methods, including conceptual and theoretical development, to discover not 'what works', but 'why things work'.},
	author = {Deaton, Angus and Cartwright, Nancy},
	date-added = {2020-09-01 20:13:39 -0400},
	date-modified = {2020-09-01 20:13:39 -0400},
	doi = {10.1016/j.socscimed.2017.12.005},
	journal = {Soc Sci Med},
	journal-full = {Social science \& medicine (1982)},
	keywords = {Balance; Bias; Economic development; External validity; Health; Precision; RCTs; Transportation of results},
	mesh = {Bias; Comprehension; Humans; Randomized Controlled Trials as Topic},
	month = {08},
	pages = {2-21},
	pmc = {PMC6019115},
	pmid = {29331519},
	pst = {ppublish},
	title = {Understanding and misunderstanding randomized controlled trials},
	volume = {210},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.1016/j.socscimed.2017.12.005}}

@article{Munafo:2017aa,
	author = {Munaf{\`o}, Marcus R and Nosek, Brian A and Bishop, Dorothy VM and Button, Katherine S and Chambers, Christopher D and Du Sert, Nathalie Percie and Simonsohn, Uri and Wagenmakers, Eric-Jan and Ware, Jennifer J and Ioannidis, John PA},
	date-added = {2020-09-01 18:27:44 -0400},
	date-modified = {2020-09-01 18:32:10 -0400},
	journal = {Nature human behaviour},
	number = {1},
	pages = {1--9},
	publisher = {Nature Publishing Group},
	title = {A manifesto for reproducible science},
	volume = {1},
	year = {2017}}

@article{Lawlor:2016aa,
	abstract = {Triangulation is the practice of obtaining more reliable answers to research questions through integrating results from several different approaches, where each approach has different key sources of potential bias that are unrelated to each other. With respect to causal questions in aetiological epidemiology, if the results of different approaches all point to the same conclusion, this strengthens confidence in the finding. This is particularly the case when the key sources of bias of some of the approaches would predict that findings would point in opposite directions if they were due to such biases. Where there are inconsistencies, understanding the key sources of bias of each approach can help to identify what further research is required to address the causal question. The aim of this paper is to illustrate how triangulation might be used to improve causal inference in aetiological epidemiology. We propose a minimum set of criteria for use in triangulation in aetiological epidemiology, summarize the key sources of bias of several approaches and describe how these might be integrated within a triangulation framework. We emphasize the importance of being explicit about the expected direction of bias within each approach, whenever this is possible, and seeking to identify approaches that would be expected to bias the true causal effect in different directions. We also note the importance, when comparing results, of taking account of differences in the duration and timing of exposures. We provide three examples to illustrate these points.},
	author = {Lawlor, Debbie A and Tilling, Kate and Davey Smith, George},
	date-added = {2020-09-01 18:23:33 -0400},
	date-modified = {2020-09-01 18:23:33 -0400},
	doi = {10.1093/ije/dyw314},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	keywords = {Aetiological epidemiology; Mendelian randomization; RCTs; causality; instrumental variables; natural experiments; negative control studies; triangulation; within-sibships studies},
	mesh = {Bias; Causality; Data Collection; Epidemiology; Humans; Mendelian Randomization Analysis; Research Design},
	month = {12},
	number = {6},
	pages = {1866-1886},
	pmc = {PMC5841843},
	pmid = {28108528},
	pst = {ppublish},
	title = {Triangulation in aetiological epidemiology},
	volume = {45},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyw314}}

@article{Matthay:2020aa,
	abstract = {Population health researchers from different fields often address similar substantive questions but rely on different study designs, reflecting their home disciplines. This is especially true in studies involving causal inference, for which semantic and substantive differences inhibit interdisciplinary dialogue and collaboration. In this paper, we group nonrandomized study designs into two categories: those that use confounder-control (such as regression adjustment or propensity score matching) and those that rely on an instrument (such as instrumental variables, regression discontinuity, or differences-in-differences approaches). Using the Shadish, Cook, and Campbell framework for evaluating threats to validity, we contrast the assumptions, strengths, and limitations of these two approaches and illustrate differences with examples from the literature on education and health. Across disciplines, all methods to test a hypothesized causal relationship involve unverifiable assumptions, and rarely is there clear justification for exclusive reliance on one method. Each method entails trade-offs between statistical power, internal validity, measurement quality, and generalizability. The choice between confounder-control and instrument-based methods should be guided by these tradeoffs and consideration of the most important limitations of previous work in the area. Our goals are to foster common understanding of the methods available for causal inference in population health research and the tradeoffs between them; to encourage researchers to objectively evaluate what can be learned from methods outside one's home discipline; and to facilitate the selection of methods that best answer the investigator's scientific questions.},
	author = {Matthay, Ellicott C and Hagan, Erin and Gottlieb, Laura M and Tan, May Lynn and Vlahov, David and Adler, Nancy E and Glymour, M Maria},
	date-added = {2020-09-01 18:22:57 -0400},
	date-modified = {2020-09-01 18:22:57 -0400},
	doi = {10.1016/j.ssmph.2019.100526},
	journal = {SSM Popul Health},
	journal-full = {SSM - population health},
	keywords = {Causal inference; Econometrics; Epidemiologic methods; Instrumental variable; Quasi-experiment; Threats to validity},
	month = {Apr},
	pages = {100526},
	pmc = {PMC6926350},
	pmid = {31890846},
	pst = {epublish},
	title = {Alternative causal inference methods in population health research: Evaluating tradeoffs and triangulating evidence},
	volume = {10},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1016/j.ssmph.2019.100526}}

@article{Rothman:2020aa,
	abstract = {P values are often taken to be something they are not, a probability measure regarding the truth of the null hypothesis. P values work well if we interpret them as an index of compatibility between the data and a spectrum of parameter values, as graphed in the P value function. But the proclivity to degrade P values into dichotomous bins corresponding to statistical significance, coupled with widespread misinterpretation of what a P value measures, is reason to seek an alternative that provides clearer, more intuitive interpretations. The S-value, or surprise index, is a possible alternative. It measures the degree to which the observed data are unusual, given the null hypothesis or other test hypothesis, by translating the data into the surprise equivalent of consecutive coin flips that all come up heads. S-values may help to avoid the worst practices regarding P values-the tendency to dichotomize them into significance tests and to interpret them as probability statements about the null hypothesis. If adopting the S-value could move us away from significance testing, it is worth a try.},
	author = {Rothman, Kenneth J},
	date-added = {2020-09-01 18:22:00 -0400},
	date-modified = {2020-09-01 18:22:00 -0400},
	doi = {10.1093/aje/kwaa137},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {P value; P value function; S-value; significance testing},
	month = {Jul},
	pmid = {32648896},
	pst = {aheadofprint},
	title = {Taken by Surprise},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa137}}

@article{Cole:2020aa,
	abstract = {Measures of information and surprise, such as the Shannon information (the $S$ value), quantify the signal present in a stream of noisy data. We illustrate the use of such information measures in the context of interpreting $P$ values as compatibility indices. $S$ values help communicate the limited information supplied by conventional statistics and cast a critical light on cutoffs used to judge and construct those statistics. Misinterpretations of statistics may be reduced by interpreting $P$ values and interval estimates using compatibility concepts and $S$ values instead of "significance" and "confidence".},
	author = {Cole, Stephen R and Edwards, Jessie K and Greenland, Sander},
	date-added = {2020-09-01 18:21:59 -0400},
	date-modified = {2020-09-01 18:21:59 -0400},
	doi = {10.1093/aje/kwaa136},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {P value; S value; compatibility; confidence intervals; information; random error; significance tests; statistical inference},
	month = {Jul},
	pmid = {32648906},
	pst = {aheadofprint},
	title = {Surprise!},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwaa136}}

@article{Lash:2014aa,
	abstract = {Quantitative bias analysis serves several objectives in epidemiological research. First, it provides a quantitative estimate of the direction, magnitude and uncertainty arising from systematic errors. Second, the acts of identifying sources of systematic error, writing down models to quantify them, assigning values to the bias parameters and interpreting the results combat the human tendency towards overconfidence in research results, syntheses and critiques and the inferences that rest upon them. Finally, by suggesting aspects that dominate uncertainty in a particular research result or topic area, bias analysis can guide efficient allocation of sparse research resources. The fundamental methods of bias analyses have been known for decades, and there have been calls for more widespread use for nearly as long. There was a time when some believed that bias analyses were rarely undertaken because the methods were not widely known and because automated computing tools were not readily available to implement the methods. These shortcomings have been largely resolved. We must, therefore, contemplate other barriers to implementation. One possibility is that practitioners avoid the analyses because they lack confidence in the practice of bias analysis. The purpose of this paper is therefore to describe what we view as good practices for applying quantitative bias analysis to epidemiological data, directed towards those familiar with the methods. We focus on answering questions often posed to those of us who advocate incorporation of bias analysis methods into teaching and research. These include the following. When is bias analysis practical and productive? How does one select the biases that ought to be addressed? How does one select a method to model biases? How does one assign values to the parameters of a bias model? How does one present and interpret a bias analysis?. We hope that our guide to good practices for conducting and presenting bias analyses will encourage more widespread use of bias analysis to estimate the potential magnitude and direction of biases, as well as the uncertainty in estimates potentially influenced by the biases. },
	author = {Lash, Timothy L and Fox, Matthew P and MacLehose, Richard F and Maldonado, George and McCandless, Lawrence C and Greenland, Sander},
	date-added = {2020-09-01 17:27:40 -0400},
	date-modified = {2020-09-01 17:27:40 -0400},
	doi = {10.1093/ije/dyu149},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	keywords = {Epidemiological biases; analysis; best practice},
	mesh = {Bias; Epidemiologic Methods; Guidelines as Topic; Humans; Statistics as Topic},
	month = {Dec},
	number = {6},
	pages = {1969-85},
	pmid = {25080530},
	pst = {ppublish},
	title = {Good practices for quantitative bias analysis},
	volume = {43},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyu149}}

@article{Baker:2016aa,
	author = {Baker, Monya},
	date-added = {2020-09-01 17:24:23 -0400},
	date-modified = {2020-09-01 17:24:23 -0400},
	doi = {10.1038/533452a},
	journal = {Nature},
	journal-full = {Nature},
	mesh = {Attitude; Data Interpretation, Statistical; Mentors; Periodicals as Topic; Publishing; Reproducibility of Results; Research; Research Design; Research Personnel; Research Support as Topic; Surveys and Questionnaires},
	month = {05},
	number = {7604},
	pages = {452-4},
	pmid = {27225100},
	pst = {ppublish},
	title = {1,500 scientists lift the lid on reproducibility},
	volume = {533},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1038/533452a}}

@article{VanderWeele:2017aa,
	abstract = {Sensitivity analysis is useful in assessing how robust an association is to potential unmeasured or uncontrolled confounding. This article introduces a new measure called the "E-value," which is related to the evidence for causality in observational studies that are potentially subject to confounding. The E-value is defined as the minimum strength of association, on the risk ratio scale, that an unmeasured confounder would need to have with both the treatment and the outcome to fully explain away a specific treatment-outcome association, conditional on the measured covariates. A large E-value implies that considerable unmeasured confounding would be needed to explain away an effect estimate. A small E-value implies little unmeasured confounding would be needed to explain away an effect estimate. The authors propose that in all observational studies intended to produce evidence for causality, the E-value be reported or some other sensitivity analysis be used. They suggest calculating the E-value for both the observed association estimate (after adjustments for measured confounders) and the limit of the confidence interval closest to the null. If this were to become standard practice, the ability of the scientific community to assess evidence from observational studies would improve considerably, and ultimately, science would be strengthened.},
	author = {VanderWeele, Tyler J and Ding, Peng},
	date-added = {2020-09-01 17:22:56 -0400},
	date-modified = {2020-09-01 17:22:56 -0400},
	doi = {10.7326/M16-2607},
	journal = {Ann Intern Med},
	journal-full = {Annals of internal medicine},
	mesh = {Confounding Factors, Epidemiologic; Epidemiologic Research Design; Humans; Observational Studies as Topic; Sensitivity and Specificity},
	month = {Aug},
	number = {4},
	pages = {268-274},
	pmid = {28693043},
	pst = {ppublish},
	title = {Sensitivity Analysis in Observational Research: Introducing the E-Value},
	volume = {167},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.7326/M16-2607}}

@article{Greenland:2020aa,
	author = {Greenland, Sander},
	date-added = {2020-09-01 17:19:52 -0400},
	date-modified = {2020-09-01 17:19:52 -0400},
	doi = {10.1093/ije/dyaa095},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {Aug},
	pmid = {32808028},
	pst = {aheadofprint},
	title = {Commentary: An argument against E-values for assessing the plausibility that an association could be explained away by residual confounding},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyaa095}}

@article{VanderWeele:2020aa,
	author = {VanderWeele, Tyler J and Mathur, Maya B},
	date-added = {2020-09-01 17:19:51 -0400},
	date-modified = {2020-09-01 17:19:51 -0400},
	doi = {10.1093/ije/dyaa094},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {Aug},
	pmid = {32743656},
	pst = {aheadofprint},
	title = {Commentary: Developing best-practice guidelines for the reporting of E-values},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyaa094}}

@article{Fox:2020ab,
	author = {Fox, Matthew P and Arah, Onyebuchi A and Stuart, Elizabeth A},
	date-added = {2020-09-01 17:19:51 -0400},
	date-modified = {2020-09-01 17:19:51 -0400},
	doi = {10.1093/ije/dyaa093},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	month = {Jul},
	pmid = {32620951},
	pst = {aheadofprint},
	title = {Commentary: The value of E-values and why they are not enough},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyaa093}}

@article{Blum:2020aa,
	abstract = {BACKGROUND: E-values are a recently introduced approach to evaluate confounding in observational studies. We aimed to empirically assess the current use of E-values in published literature.
METHODS: We conducted a systematic literature search for all publications, published up till the end of 2018, which cited at least one of two inceptive E-value papers and presented E-values for original data. For these case publications we identified control publications, matched by journal and issue, where the authors had not calculated E-values.
RESULTS: In total, 87 papers presented 516 E-values. Of the 87 papers, 14 concluded that residual confounding likely threatens at least some of the main conclusions. Seven of these 14 named potential uncontrolled confounders. 19 of 87 papers related E-value magnitudes to expected strengths of field-specific confounders. The median E-value was 1.88, 1.82, and 2.02 for the 43, 348, and 125 E-values where confounding was felt likely to affect the results, unlikely to affect the results, or not commented upon, respectively. The 69 case-control publication pairs dealt with effect sizes of similar magnitude. Of 69 control publications, 52 did not comment on unmeasured confounding and 44/69 case publications concluded that confounding was unlikely to affect study conclusions.
CONCLUSIONS: Few papers using E-values conclude that confounding threatens their results, and their E-values overlap in magnitude with those of papers acknowledging susceptibility to confounding. Facile automation in calculating E-values may compound the already poor handling of confounding. E-values should not be a substitute for careful consideration of potential sources of unmeasured confounding. If used, they should be interpreted in the context of expected confounding in specific fields.},
	author = {Blum, Manuel R and Tan, Yuan Jin and Ioannidis, John P A},
	date-added = {2020-09-01 17:19:50 -0400},
	date-modified = {2020-09-01 17:19:50 -0400},
	doi = {10.1093/ije/dyz261},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	keywords = {E-value; confounding; literature review; observational study; sensitivity analysis},
	month = {Jan},
	pmid = {31930286},
	pst = {aheadofprint},
	title = {Use of E-values for addressing confounding in observational studies-an empirical assessment of the literature},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyz261}}

@article{Ioannidis:2005aa,
	abstract = {There is increasing concern that most current published research findings are false. The probability that a research claim is true may depend on study power and bias, the number of other studies on the same question, and, importantly, the ratio of true to no relationships among the relationships probed in each scientific field. In this framework, a research finding is less likely to be true when the studies conducted in a field are smaller; when effect sizes are smaller; when there is a greater number and lesser preselection of tested relationships; where there is greater flexibility in designs, definitions, outcomes, and analytical modes; when there is greater financial and other interest and prejudice; and when more teams are involved in a scientific field in chase of statistical significance. Simulations show that for most study designs and settings, it is more likely for a research claim to be false than true. Moreover, for many current scientific fields, claimed research findings may often be simply accurate measures of the prevailing bias. In this essay, I discuss the implications of these problems for the conduct and interpretation of research.},
	author = {Ioannidis, John P A},
	date-added = {2020-09-01 17:17:31 -0400},
	date-modified = {2020-09-01 17:17:31 -0400},
	doi = {10.1371/journal.pmed.0020124},
	journal = {PLoS Med},
	journal-full = {PLoS medicine},
	mesh = {Bias; Data Interpretation, Statistical; Likelihood Functions; Meta-Analysis as Topic; Odds Ratio; Publishing; Reproducibility of Results; Research Design; Sample Size},
	month = {Aug},
	number = {8},
	pages = {e124},
	pmc = {PMC1182327},
	pmid = {16060722},
	pst = {ppublish},
	title = {Why most published research findings are false},
	volume = {2},
	year = {2005},
	bdsk-url-1 = {https://doi.org/10.1371/journal.pmed.0020124}}

@article{Maldonado:2016aa,
	abstract = {In this commentary I review the fundamentals of counterfactual theory and its role in causal reasoning in epidemiology. I consider if counterfactual theory dictates that causal questions must be framed in terms of well-defined interventions. I conclude that it does not. I hypothesize that the interventionist approach to causal inference in epidemiology stems from elevating the randomized trial design to the gold standard for thinking about causal inference. I suggest that instead the gold standard we should use for thinking about causal inference in epidemiology is the thought experiment that, for example, compares an actual disease frequency under one exposure level with a counterfactual disease frequency under a different exposure level (as discussed in Greenland and Robins (1986) and Maldonado and Greenland (2002)). I also remind us that no method should be termed "causal" unless it addresses the effect of other biases in addition to the problem of confounding.},
	author = {Maldonado, George},
	date-added = {2020-09-01 16:21:43 -0400},
	date-modified = {2020-09-01 16:21:43 -0400},
	doi = {10.1016/j.annepidem.2016.08.017},
	journal = {Ann Epidemiol},
	journal-full = {Annals of epidemiology},
	keywords = {Causal reasoning; Counterfactual theory},
	mesh = {Causality; Confounding Factors, Epidemiologic; Decision Theory; Epidemiologic Methods; Humans; Sensitivity and Specificity},
	month = {10},
	number = {10},
	pages = {681-682},
	pmid = {27641317},
	pst = {ppublish},
	title = {The role of counterfactual theory in causal reasoning},
	volume = {26},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1016/j.annepidem.2016.08.017}}

@article{Schwartz:2016aa,
	abstract = {The requirement for framing all causal questions as well-defined interventions is being promoted in the causal inference literature within epidemiology. One can consider this perspective as an intervention on the field which requires a refocusing of epidemiologic questions and retooling of epidemiologic methods. Although this intervention has produced many positive results, we think that its underlying assumptions and the possibilities of unintended consequences warrant examination. In so doing, we argue that this approach can lead to the neglect of causal identification as a useful link between associations and the estimation of intervention effects.},
	author = {Schwartz, Sharon and Gatto, Nicolle M and Campbell, Ulka B},
	date-added = {2020-09-01 16:20:15 -0400},
	date-modified = {2020-09-01 16:20:15 -0400},
	doi = {10.1016/j.annepidem.2016.03.013},
	journal = {Ann Epidemiol},
	journal-full = {Annals of epidemiology},
	keywords = {Causal effects; Counterfactuals; Potential outcomes},
	mesh = {Causality; Effect Modifier, Epidemiologic; Epidemiologic Methods; Female; Humans; Male; Models, Statistical; Research Design},
	month = {10},
	number = {10},
	pages = {669-673},
	pmid = {27237595},
	pst = {ppublish},
	title = {Causal identification: a charge of epidemiology in danger of marginalization},
	volume = {26},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1016/j.annepidem.2016.03.013}}

@article{Schwartz:2017aa,
	author = {Schwartz, Sharon and Gatto, Nicolle M and Campbell, Ulka B},
	date-added = {2020-09-01 16:20:11 -0400},
	date-modified = {2020-09-01 16:20:11 -0400},
	doi = {10.1016/j.annepidem.2017.05.012},
	journal = {Ann Epidemiol},
	journal-full = {Annals of epidemiology},
	mesh = {Causality; Confounding Factors, Epidemiologic; Epidemiologic Research Design; Epidemiologic Studies; Humans},
	month = {Jun},
	number = {6},
	pages = {402-405},
	pmid = {28641760},
	pst = {ppublish},
	title = {Heeding the call for less casual causal inferences: the utility of realized (quantitative) causal effects},
	volume = {27},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1016/j.annepidem.2017.05.012}}

@article{Kaufman:2016aa,
	author = {Kaufman, Jay S},
	date-added = {2020-09-01 16:19:45 -0400},
	date-modified = {2020-09-01 16:19:45 -0400},
	doi = {10.1016/j.annepidem.2016.08.018},
	journal = {Ann Epidemiol},
	journal-full = {Annals of epidemiology},
	keywords = {Causal identification; Epidemiology},
	mesh = {Causality; Epidemiologic Methods; Humans; Research Design},
	month = {10},
	number = {10},
	pages = {683-684},
	pmid = {27641315},
	pst = {ppublish},
	title = {There is no virtue in vagueness: Comment on: Causal Identification: A Charge of Epidemiology in Danger of Marginalization by Sharon Schwartz, Nicolle M. Gatto, and Ulka B. Campbell},
	volume = {26},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1016/j.annepidem.2016.08.018}}

@article{Hernan:2016aa,
	abstract = {"Can this number be interpreted as a causal effect?" is a key question for scientists and decision makers. The potential outcomes approach, a quantitative counterfactual theory, describes conditions under which the question can be answered affirmatively. This article reviews one of those conditions, known as consistency, and its implications for real world decisions.},
	author = {Hern{\'a}n, Miguel A},
	date-added = {2020-09-01 16:19:37 -0400},
	date-modified = {2020-09-01 16:19:37 -0400},
	doi = {10.1016/j.annepidem.2016.08.016},
	journal = {Ann Epidemiol},
	journal-full = {Annals of epidemiology},
	keywords = {Causal inference; Consistency; Counterfactuals; Potential outcomes; Well-defined interventions},
	mesh = {Causality; Confounding Factors, Epidemiologic; Decision Making; Epidemiologic Studies; Female; Humans; Male; Research Design; Water},
	month = {10},
	number = {10},
	pages = {674-680},
	pmc = {PMC5207342},
	pmid = {27641316},
	pst = {ppublish},
	title = {Does water kill? A call for less casual causal inferences},
	volume = {26},
	year = {2016},
	bdsk-url-1 = {https://doi.org/10.1016/j.annepidem.2016.08.016}}

@article{Vandenbroucke:2018aa,
	abstract = {Where do new research questions come from? This is at best only partially taught in courses or textbooks about clinical or epidemiological research. Methods are taught under the assumption that a researcher already knows the research question and knows which methods will fit that question. Similarly, the real complexity of the thought processes that lead to a scientific undertaking is almost never described in published papers. In this paper, we first discuss how to get an idea that is worth researching. We describe sources of new ideas and how to foster a creative attitude by "cultivating your thoughts". Only a few of these ideas will make it into a study. Next, we describe how to sharpen and focus a research question so that a study becomes feasible and a valid test of the underlying idea. To do this, the idea needs to be "pruned". Pruning a research question means cutting away anything that is unnecessary, so that only the essence remains. This includes determining both the latent and the stated objectives, specific pruning questions, and the use of specific schemes to structure reasoning. After this, the following steps include preparation of a brief protocol, conduct of a pilot study, and writing a draft of the paper including draft tables. Then you are ready to carry out your research.},
	author = {Vandenbroucke, Jan P and Pearce, Neil},
	date-added = {2020-09-01 16:16:40 -0400},
	date-modified = {2020-09-01 16:16:40 -0400},
	doi = {10.2147/CLEP.S142940},
	journal = {Clin Epidemiol},
	journal-full = {Clinical epidemiology},
	keywords = {research questions; study design; writing a paper},
	pages = {253-264},
	pmc = {PMC5846748},
	pmid = {29563838},
	pst = {epublish},
	title = {From ideas to studies: how to get ideas and sharpen them into research questions},
	volume = {10},
	year = {2018},
	bdsk-url-1 = {https://doi.org/10.2147/CLEP.S142940}}

@article{Fox:2020aa,
	abstract = {Epidemiologic methods have advanced tremendously in the last several decades. As important as they are, even the most sophisticated approaches are unable to provide meaningful answers when the user lacks a clear study question. Yet, instructors have more and more resources on how to conduct studies and analyze data but few resources on how to ask clearly defined study questions that will guide those methods. Training programs have limited time for coursework, and if novel statistical estimation methods become the focus of instruction, programs that go this route may end up underemphasizing the process of asking good study questions, designing robust studies, considering potential biases in the collected data, and appropriately interpreting the results of the analysis. Given the demands for space in curricula, now is an appropriate time to reevaluate what we teach epidemiology doctoral students. We advocate that programs place a renewed focus on asking good study questions and following a comprehensive approach to study design and data analysis in which questions guide the choice of appropriate methods, helping us avoid methods for methods' sake and highlighting when application of a new method can provide the opportunity to answer questions that were intractable with traditional approaches.},
	author = {Fox, Matthew P and Edwards, Jessie K and Platt, Robert and Balzer, Laura B},
	date-added = {2020-09-01 16:16:14 -0400},
	date-modified = {2020-09-01 16:16:14 -0400},
	doi = {10.1093/aje/kwz233},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {causal inference; epidemiologic methods; novel methods; study questions; teaching; training},
	mesh = {Education, Graduate; Epidemiology},
	month = {04},
	number = {4},
	pages = {261-264},
	pmc = {PMC7305787},
	pmid = {31595956},
	pst = {ppublish},
	title = {The Critical Importance of Asking Good Questions: The Role of Epidemiology Doctoral Training Programs},
	volume = {189},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwz233}}

@article{Richiardi:2013lc,
	author = {Richiardi, Lorenzo and Pizzi, Costanza and Pearce, Neil},
	date-added = {2020-08-31 17:22:20 -0400},
	date-modified = {2020-08-31 17:22:20 -0400},
	doi = {10.1093/ije/dyt103},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Aug},
	number = {4},
	pages = {1018-22},
	pmid = {24062290},
	pst = {ppublish},
	title = {Commentary: Representativeness is usually not necessary and often should be avoided},
	volume = {42},
	year = {2013},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt103}}

@article{Nohr:2013gv,
	author = {Nohr, Ellen A and Olsen, J{\o}rn},
	date-added = {2020-08-31 17:21:45 -0400},
	date-modified = {2020-08-31 17:21:45 -0400},
	doi = {10.1093/ije/dyt102},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Aug},
	number = {4},
	pages = {1016-7},
	pmid = {24062289},
	pst = {ppublish},
	title = {Commentary: Epidemiologists have debated representativeness for more than 40 years--has the time come to move on?},
	volume = {42},
	year = {2013},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt102}}

@article{Elwood:2013dk,
	author = {Elwood, J Mark},
	date-added = {2020-08-31 17:21:24 -0400},
	date-modified = {2020-08-31 17:21:24 -0400},
	doi = {10.1093/ije/dyt101},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Aug},
	number = {4},
	pages = {1014-5},
	pmid = {24062288},
	pst = {ppublish},
	title = {Commentary: On representativeness},
	volume = {42},
	year = {2013},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt101}}

@article{Lash:2017la,
	abstract = {In the last few years, stakeholders in the scientific community have raised alarms about a perceived lack of reproducibility of scientific results. In reaction, guidelines for journals have been promulgated and grant applicants have been asked to address the rigor and reproducibility of their proposed projects. Neither solution addresses a primary culprit, which is the culture of null hypothesis significance testing that dominates statistical analysis and inference. In an innovative research enterprise, selection of results for further evaluation based on null hypothesis significance testing is doomed to yield a low proportion of reproducible results and a high proportion of effects that are initially overestimated. In addition, the culture of null hypothesis significance testing discourages quantitative adjustments to account for systematic errors and quantitative incorporation of prior information. These strategies would otherwise improve reproducibility and have not been previously proposed in the widely cited literature on this topic. Without discarding the culture of null hypothesis significance testing and implementing these alternative methods for statistical analysis and inference, all other strategies for improving reproducibility will yield marginal gains at best.},
	author = {Lash, Timothy L},
	date-added = {2020-08-31 17:15:55 -0400},
	date-modified = {2020-08-31 17:15:55 -0400},
	doi = {10.1093/aje/kwx261},
	journal = {Am J Epidemiol},
	journal-full = {American journal of epidemiology},
	keywords = {data interpretation, statistical; epidemiologic methods; epidemiologic research design; null hypothesis; reproducibility of results; significance testing; statistical significance; statistics},
	mesh = {Data Interpretation, Statistical; False Positive Reactions; Humans; Predictive Value of Tests; Probability; Reproducibility of Results; Research; Research Design},
	month = {09},
	number = {6},
	pages = {627-635},
	pmid = {28938715},
	pst = {ppublish},
	title = {The Harm Done to Reproducibility by the Culture of Null Hypothesis Significance Testing},
	volume = {186},
	year = {2017},
	bdsk-url-1 = {https://doi.org/10.1093/aje/kwx261}}

@article{Ahern:2020xx,
	abstract = {Increased transparency in study design and analysis is one proposed solution to the perceived reproducibility crisis facing science. Systematic review and meta-analysis-through which individual studies on a specific association are ascertained, assessed for quality and quantitatively combined-is a critical process for building consensus in medical research. However, the conventional publication model creates static evidence summaries that force the quality assessment criteria and analytical choices of a small number of authors onto all stakeholders, some of whom will have different views on the quality assessment and key features of the analysis. This leads to discordant inferences from meta-analysis results and delayed arrival at consensus. We propose a shift to interactive meta-analysis, through which stakeholders can take control of the evidence synthesis using their own quality criteria and preferred analytic approach-including the option to incorporate prior information on the association in question-to reveal how their summary estimate differs from that reported by the original analysts. We demonstrate this concept using a web-based meta-analysis of the association between genetic variation in a key tamoxifen-metabolising enzyme and breast cancer recurrence in tamoxifen-treated women. We argue that interactive meta-analyses would speed consensus-building to the degree that they reveal invariance of inferences to different study selection and analysis criteria. On the other hand, when inferences are found to differ substantially as a function of these choices, the disparities highlight where future research resources should be invested to resolve lingering sources of disagreement.},
	author = {Ahern, Thomas P and MacLehose, Richard F and Haines, Laura and Cronin-Fenton, Deirdre P and Damkier, Per and Collin, Lindsay J and Lash, Timothy L},
	date-added = {2020-08-31 17:15:37 -0400},
	date-modified = {2020-08-31 17:15:37 -0400},
	doi = {10.1136/bmjebm-2019-111308},
	journal = {BMJ Evid Based Med},
	journal-full = {BMJ evidence-based medicine},
	keywords = {breast tumours; statistics & research methods},
	month = {Mar},
	pmid = {32220861},
	pst = {aheadofprint},
	title = {Improving the transparency of meta-analyses with interactive web applications},
	year = {2020},
	bdsk-url-1 = {https://doi.org/10.1136/bmjebm-2019-111308}}

@article{Rothman:2014ht,
	author = {Rothman, Kj and Hatch, Ee and Gallacher, Jej},
	date-added = {2020-08-31 17:13:53 -0400},
	date-modified = {2020-08-31 17:13:53 -0400},
	doi = {10.1093/ije/dyt265},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies},
	month = {Apr},
	number = {2},
	pages = {633-4},
	pmid = {24396049},
	pst = {ppublish},
	title = {Representativeness is not helpful in studying heterogeneity of effects across subgroups},
	volume = {43},
	year = {2014},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dyt265}}

@article{Rothman:2013kc,
	author = {Rothman, Kenneth J and Gallacher, John E J and Hatch, Elizabeth E},
	date-added = {2020-08-31 17:13:52 -0400},
	date-modified = {2020-08-31 17:13:52 -0400},
	doi = {10.1093/ije/dys223},
	journal = {Int J Epidemiol},
	journal-full = {International journal of epidemiology},
	mesh = {Epidemiologic Studies; Sampling Studies; Statistics as Topic},
	month = {Aug},
	number = {4},
	pages = {1012-4},
	pmc = {PMC3888189},
	pmid = {24062287},
	pst = {ppublish},
	title = {Why representativeness should be avoided},
	volume = {42},
	year = {2013},
	bdsk-url-1 = {https://doi.org/10.1093/ije/dys223}}
